| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.712 | 0.007 | 0.879 | Aldehyde oxidase inhibitor | 0.472 0.037 CID_108063 0.833 0.004 CID_11318 0.879 0.004 CID_8663 0.879 0.004 CID_7005 | CID_7005 | |
| 0.7 | 0.007 | 0.724 | 5 Hydroxytryptamine release stimulant | 0.489 0.029 CID_108063 0.648 0.01 CID_11318 0.724 0.005 CID_8663 0.601 0.014 CID_7005 | CID_8663 | |
| 0.673 | 0.004 | 0.711 | GABA C receptor rho-3 antagonist | 0.494 0.027 CID_108063 0.653 0.004 CID_11318 0.672 0.004 CID_8663 0.711 0.003 CID_7005 | CID_7005 | |
| 0.649 | 0.03 | 0.8 | Caspase 9 stimulant | 0.742 0.019 CID_108063 0.8 0.011 CID_11318 0.765 0.016 CID_8663 0.779 0.014 CID_7005 | CID_11318 | |
| 0.606 | 0.004 | 0.725 | Peroxidase inhibitor | 0.368 0.025 CID_108063 0.671 0.003 CID_11318 0.725 0.003 CID_8663 0.693 0.003 CID_7005 | CID_8663 | |
| 0.593 | 0.004 | 0.593 | Alpha-N-acetylglucosaminidase inhibitor | 0.335 0.013 CID_108063 0.403 0.009 CID_11318 0.448 0.007 CID_8663 0.448 0.007 CID_7005 | ||
| 0.599 | 0.011 | 0.624 | 5 Hydroxytryptamine release inhibitor | 0.395 0.081 CID_108063 0.511 0.029 CID_11318 0.624 0.008 CID_8663 0.546 0.02 CID_7005 | CID_8663 | |
| 0.578 | 0.01 | 0.578 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.431 0.075 CID_108063 0.474 0.047 CID_11318 0.46 0.055 CID_8663 0.497 0.035 CID_7005 | ||
| 0.545 | 0.014 | 0.549 | Calcium channel L-type activator | 0.462 0.045 CID_11318 0.549 0.013 CID_8663 0.492 0.031 CID_7005 | CID_8663 | |
| 0.531 | 0.01 | 0.639 | Superoxide dismutase inhibitor | 0.236 0.084 CID_108063 0.551 0.009 CID_11318 0.639 0.005 CID_8663 0.501 0.013 CID_7005 | CID_8663 | |
| 0.505 | 0.004 | 0.505 | 5 Hydroxytryptamine uptake stimulant | 0.384 0.017 CID_108063 0.491 0.005 CID_11318 0.5 0.004 CID_8663 0.472 0.005 CID_7005 | ||
| 0.494 | 0.004 | 0.494 | GABA C receptor agonist | 0.188 0.023 CID_108063 0.348 0.007 CID_11318 0.392 0.005 CID_8663 0.392 0.005 CID_7005 | ||
| 0.508 | 0.026 | 0.57 | Histamine release inhibitor | 0.341 0.104 CID_108063 0.521 0.022 CID_11318 0.57 0.013 CID_8663 0.555 0.015 CID_7005 | CID_8663 | |
| 0.469 | 0.004 | 0.607 | Tyrosine 3 hydroxylase inhibitor | 0.289 0.039 CID_108063 0.607 0.003 CID_11318 0.559 0.003 CID_8663 0.486 0.004 CID_7005 | CID_11318 | |
| 0.471 | 0.013 | 0.538 | Sigma receptor agonist | 0.538 0.007 CID_108063 0.419 0.019 CID_8663 0.149 0.086 CID_7005 | CID_108063 | |
| 0.451 | 0.004 | 0.706 | Alcohol oxidase inhibitor | 0.099 0.018 CID_108063 0.374 0.004 CID_11318 0.706 0.003 CID_8663 0.49 0.004 CID_7005 | CID_8663 | |
| 0.473 | 0.037 | 0.549 | Cholesterol antagonist | 0.34 0.069 CID_108063 0.516 0.03 CID_11318 0.549 0.025 CID_8663 0.517 0.03 CID_7005 | CID_8663 | |
| 0.443 | 0.012 | 0.443 | Calcium channel activator | 0.325 0.069 CID_108063 0.405 0.023 CID_11318 0.423 0.017 CID_8663 0.386 0.03 CID_7005 | ||
| 0.413 | 0.004 | 0.413 | Ferrochelatase inhibitor | 0.2 0.022 CID_108063 0.23 0.016 CID_11318 0.261 0.012 CID_8663 0.261 0.012 CID_7005 | ||
| 0.431 | 0.046 | 0.432 | Vasodilator, peripheral | 0.214 0.16 CID_108063 0.379 0.062 CID_11318 0.432 0.046 CID_8663 0.392 0.058 CID_7005 | CID_8663 | |
| 0.426 | 0.044 | 0.437 | MAP kinase kinase 6 inhibitor | 0.227 0.222 CID_11318 0.232 0.215 CID_8663 0.437 0.039 CID_7005 | CID_7005 | |
| 0.376 | 0.004 | 0.397 | Porphobilinogen synthase inhibitor | 0.097 0.037 CID_108063 0.334 0.005 CID_11318 0.397 0.004 CID_8663 0.397 0.004 CID_7005 | CID_7005 | |
| 0.356 | 0.004 | 0.379 | GABA C receptor rho-2 antagonist | 0.197 0.031 CID_108063 0.294 0.006 CID_11318 0.347 0.004 CID_8663 0.379 0.004 CID_7005 | CID_7005 | |
| 0.372 | 0.02 | 0.384 | Anesthetic general | 0.163 0.1 CID_108063 0.289 0.036 CID_11318 0.384 0.019 CID_8663 0.31 0.031 CID_7005 | CID_8663 | |
| 0.353 | 0.005 | 0.379 | Succinate dehydrogenase inhibitor | 0.247 0.023 CID_108063 0.36 0.005 CID_11318 0.379 0.004 CID_8663 0.347 0.005 CID_7005 | CID_8663 | |
| 0.346 | 0.008 | 0.346 | UDP-glucose 4-epimerase inhibitor | 0.221 0.016 CID_108063 0.287 0.011 CID_11318 0.322 0.009 CID_8663 0.322 0.009 CID_7005 | ||
| 0.375 | 0.042 | 0.4 | Aryl hydrocarbon receptor agonist | 0.322 0.055 CID_11318 0.388 0.04 CID_8663 0.4 0.037 CID_7005 | CID_7005 | |
| 0.354 | 0.023 | 0.431 | RNA-directed DNA polymerase inhibitor | 0.223 0.071 CID_108063 0.431 0.015 CID_11318 0.361 0.023 CID_8663 0.408 0.017 CID_7005 | CID_11318 | |
| 0.331 | 0.004 | 0.331 | 5 Hydroxytryptamine 3E antagonist | 0.239 0.022 CID_108063 0.244 0.019 CID_11318 0.27 0.009 CID_8663 0.257 0.013 CID_7005 | ||
| 0.341 | 0.014 | 0.431 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.202 0.071 CID_108063 0.431 0.006 CID_11318 0.391 0.008 CID_8663 0.411 0.007 CID_7005 | CID_11318 | |
| 0.348 | 0.025 | 0.348 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.211 0.083 CID_8663 0.238 0.067 CID_7005 | ||
| 0.327 | 0.005 | 0.327 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.187 0.018 CID_108063 0.218 0.013 CID_11318 0.248 0.01 CID_8663 0.248 0.01 CID_7005 | ||
| 0.351 | 0.034 | 0.361 | Insulysin inhibitor | 0.204 0.151 CID_108063 0.361 0.031 CID_11318 0.357 0.032 CID_8663 0.323 0.046 CID_7005 | CID_11318 | |
| 0.347 | 0.03 | 0.347 | Interleukin agonist | 0.208 0.114 CID_108063 0.345 0.03 CID_11318 0.325 0.037 CID_8663 0.334 0.034 CID_7005 | ||
| 0.317 | 0.004 | 0.325 | GABA C receptor antagonist | 0.171 0.021 CID_108063 0.243 0.007 CID_11318 0.282 0.005 CID_8663 0.325 0.004 CID_7005 | CID_7005 | |
| 0.322 | 0.013 | 0.429 | Neurotrophic factor enhancer | 0.236 0.047 CID_108063 0.417 0.005 CID_11318 0.429 0.005 CID_8663 0.375 0.007 CID_7005 | CID_8663 | |
| 0.335 | 0.027 | 0.335 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.162 0.113 CID_11318 0.182 0.092 CID_8663 0.204 0.073 CID_7005 | ||
| 0.316 | 0.008 | 0.594 | Cystathionine beta-synthase inhibitor | 0.202 0.024 CID_108063 0.594 0.003 CID_11318 0.528 0.003 CID_8663 0.543 0.003 CID_7005 | CID_11318 | |
| 0.325 | 0.019 | 0.325 | Gastrin inhibitor | 0.212 0.13 CID_108063 0.239 0.093 CID_11318 0.268 0.06 CID_8663 0.282 0.047 CID_7005 | ||
| 0.307 | 0.005 | 0.307 | Triose-phosphate isomerase inhibitor | 0.146 0.021 CID_108063 0.213 0.009 CID_11318 0.242 0.007 CID_8663 0.242 0.007 CID_7005 | ||
| 0.331 | 0.031 | 0.37 | Cyclic AMP phosphodiesterase inhibitor | 0.189 0.102 CID_108063 0.37 0.021 CID_11318 0.357 0.024 CID_8663 0.342 0.028 CID_7005 | CID_11318 | |
| 0.307 | 0.011 | 0.404 | Aldehyde dehydrogenase inhibitor | 0.126 0.065 CID_108063 0.287 0.013 CID_11318 0.404 0.005 CID_8663 0.385 0.006 CID_7005 | CID_8663 | |
| 0.305 | 0.01 | 0.331 | Nitric-oxide synthase stimulant | 0.239 0.04 CID_108063 0.292 0.013 CID_11318 0.331 0.006 CID_8663 0.31 0.009 CID_7005 | CID_8663 | |
| 0.35 | 0.055 | 0.37 | Vasodilator, coronary | 0.336 0.062 CID_108063 0.37 0.046 CID_11318 0.351 0.055 CID_8663 0.337 0.062 CID_7005 | CID_11318 | |
| 0.344 | 0.052 | 0.521 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.521 0.017 CID_11318 0.391 0.04 CID_8663 0.475 0.023 CID_7005 | CID_11318 | |
| 0.312 | 0.023 | 0.312 | 5 Hydroxytryptamine 1E antagonist | 0.179 0.155 CID_108063 0.269 0.055 CID_11318 0.311 0.023 CID_8663 0.289 0.037 CID_7005 | ||
| 0.291 | 0.004 | 0.384 | Phenylalanine 4-hydroxylase inhibitor | 0.111 0.021 CID_108063 0.375 0.003 CID_11318 0.384 0.003 CID_8663 0.333 0.004 CID_7005 | CID_8663 | |
| 0.33 | 0.045 | 0.33 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.248 0.108 CID_11318 0.239 0.117 CID_8663 0.255 0.101 CID_7005 | ||
| 0.289 | 0.004 | 0.469 | Creatine kinase inhibitor | 0.172 0.016 CID_108063 0.432 0.003 CID_11318 0.464 0.002 CID_8663 0.469 0.002 CID_7005 | CID_7005 | |
| 0.288 | 0.006 | 0.356 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 CID_108063 0.356 0.004 CID_11318 0.275 0.008 CID_8663 0.297 0.005 CID_7005 | CID_11318 | |
| 0.294 | 0.013 | 0.294 | 3C-like protease (Human coronavirus) inhibitor | 0.141 0.117 CID_108063 0.175 0.069 CID_11318 0.251 0.027 CID_8663 0.205 0.049 CID_7005 | ||
| 0.298 | 0.018 | 0.387 | NOS3 expression enhancer | 0.288 0.02 CID_11318 0.387 0.009 CID_8663 0.326 0.014 CID_7005 | CID_8663 | |
| 0.361 | 0.081 | 0.361 | Calpain 2 inhibitor | 0.205 0.183 CID_11318 0.271 0.134 CID_8663 0.301 0.114 CID_7005 | ||
| 0.278 | 0.004 | 0.278 | GABA C receptor rho-1 antagonist | 0.14 0.026 CID_108063 0.213 0.006 CID_11318 0.247 0.004 CID_8663 0.275 0.004 CID_7005 | ||
| 0.304 | 0.034 | 0.304 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.135 0.1 CID_8663 0.134 0.101 CID_7005 | ||
| 0.272 | 0.004 | 0.272 | 5 Hydroxytryptamine 3A agonist | 0.132 0.047 CID_108063 0.214 0.011 CID_11318 0.261 0.005 CID_8663 0.233 0.008 CID_7005 | ||
| 0.328 | 0.067 | 0.587 | Caspase 3 stimulant | 0.587 0.011 CID_108063 0.455 0.028 CID_11318 0.478 0.024 CID_8663 0.524 0.017 CID_7005 | CID_108063 | |
| 0.269 | 0.009 | 0.269 | Adenylate kinase inhibitor | 0.146 0.028 CID_108063 0.18 0.018 CID_11318 0.202 0.015 CID_8663 0.202 0.015 CID_7005 | ||
| 0.302 | 0.043 | 0.342 | DNA synthesis inhibitor | 0.223 0.09 CID_108063 0.305 0.042 CID_11318 0.304 0.042 CID_8663 0.342 0.032 CID_7005 | CID_7005 | |
| 0.309 | 0.054 | 0.392 | DNA damaging | 0.355 0.039 CID_108063 0.392 0.03 CID_11318 0.341 0.044 CID_8663 0.375 0.034 CID_7005 | CID_11318 | |
| 0.265 | 0.011 | 0.328 | Carbonic anhydrase XV inhibitor | 0.124 0.044 CID_108063 0.267 0.01 CID_11318 0.328 0.006 CID_8663 0.293 0.008 CID_7005 | CID_8663 | |
| 0.257 | 0.005 | 0.306 | HIV-1 integrase (Overall Integration) inhibitor | 0.145 0.027 CID_108063 0.306 0.004 CID_11318 0.261 0.004 CID_8663 0.277 0.004 CID_7005 | CID_11318 | |
| 0.295 | 0.047 | 0.295 | Ca(v)3.3 blocker | |||
| 0.302 | 0.055 | 0.385 | Transcription factor STAT inhibitor | 0.385 0.023 CID_11318 0.318 0.046 CID_8663 0.373 0.026 CID_7005 | CID_11318 | |
| 0.28 | 0.036 | 0.28 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.29 | 0.045 | 0.29 | Psychostimulant | 0.161 0.107 CID_108063 0.191 0.085 CID_11318 0.264 0.054 CID_8663 0.265 0.053 CID_7005 | ||
| 0.284 | 0.041 | 0.284 | MAP kinase kinase 2 inhibitor | 0.191 0.087 CID_11318 0.268 0.046 CID_8663 0.251 0.053 CID_7005 | ||
| 0.246 | 0.005 | 0.246 | CYP2A6 inhibitor | 0.119 0.027 CID_108063 0.129 0.023 CID_11318 0.156 0.015 CID_8663 0.162 0.013 CID_7005 | ||
| 0.291 | 0.05 | 0.462 | Pyruvate kinase inhibitor | 0.462 0.013 CID_11318 0.391 0.022 CID_8663 0.415 0.018 CID_7005 | CID_11318 | |
| 0.247 | 0.007 | 0.272 | CF transmembrane conductance regulator agonist | 0.156 0.066 CID_108063 0.217 0.014 CID_11318 0.265 0.005 CID_8663 0.272 0.005 CID_7005 | CID_7005 | |
| 0.263 | 0.025 | 0.381 | Amylase inhibitor | 0.138 0.07 CID_108063 0.37 0.011 CID_11318 0.381 0.01 CID_8663 0.329 0.015 CID_7005 | CID_8663 | |
| 0.244 | 0.008 | 0.244 | NADH dehydrogenase inhibitor | 0.155 0.016 CID_108063 0.191 0.011 CID_11318 0.237 0.008 CID_8663 0.214 0.009 CID_7005 | ||
| 0.271 | 0.039 | 0.271 | CDC-like kinase 4 inhibitor | |||
| 0.239 | 0.01 | 0.364 | Histidine decarboxylase inhibitor | 0.103 0.031 CID_108063 0.273 0.008 CID_11318 0.364 0.004 CID_8663 0.333 0.005 CID_7005 | CID_8663 | |
| 0.288 | 0.059 | 0.378 | Transcription factor STAT3 inhibitor | 0.378 0.024 CID_11318 0.298 0.054 CID_8663 0.356 0.031 CID_7005 | CID_11318 | |
| 0.246 | 0.018 | 0.325 | Hexokinase inhibitor | 0.251 0.017 CID_11318 0.281 0.013 CID_8663 0.325 0.008 CID_7005 | CID_7005 | |
| 0.243 | 0.015 | 0.317 | ATPase inhibitor | 0.317 0.005 CID_108063 0.24 0.016 CID_11318 0.243 0.015 CID_8663 0.268 0.01 CID_7005 | CID_108063 | |
| 0.296 | 0.068 | 0.461 | Hypoxia-inducible factor 1 alpha inhibitor | 0.284 0.074 CID_108063 0.461 0.018 CID_11318 0.4 0.03 CID_8663 0.412 0.027 CID_7005 | CID_11318 | |
| 0.234 | 0.008 | 0.234 | Photosensitizer | 0.141 0.037 CID_108063 0.171 0.021 CID_11318 0.229 0.008 CID_8663 0.223 0.009 CID_7005 | ||
| 0.334 | 0.109 | 0.558 | 15-Lipoxygenase inhibitor | 0.234 0.178 CID_108063 0.558 0.031 CID_11318 0.465 0.049 CID_8663 0.475 0.046 CID_7005 | CID_11318 | |
| 0.302 | 0.078 | 0.509 | 12-Lipoxygenase inhibitor | 0.509 0.02 CID_11318 0.437 0.031 CID_8663 0.455 0.028 CID_7005 | CID_11318 | |
| 0.248 | 0.026 | 0.264 | Histone acetyltransferase inhibitor | 0.262 0.022 CID_11318 0.23 0.036 CID_8663 0.264 0.021 CID_7005 | CID_7005 | |
| 0.232 | 0.012 | 0.232 | Nav1.6 sodium channel blocker | 0.115 0.104 CID_108063 0.158 0.046 CID_11318 0.183 0.026 CID_8663 0.204 0.018 CID_7005 | ||
| 0.263 | 0.044 | 0.263 | Neuropeptide Y2 antagonist | 0.212 0.099 CID_11318 0.255 0.052 CID_8663 0.232 0.074 CID_7005 | ||
| 0.257 | 0.04 | 0.313 | Non-steroidal antiinflammatory agent | 0.154 0.11 CID_108063 0.313 0.025 CID_11318 0.285 0.032 CID_8663 0.298 0.029 CID_7005 | CID_11318 | |
| 0.248 | 0.033 | 0.248 | MAP kinase kinase 3 inhibitor | 0.185 0.171 CID_7005 | ||
| 0.226 | 0.013 | 0.237 | Arachidonic acid antagonist | 0.213 0.022 CID_108063 0.232 0.011 CID_11318 0.237 0.009 CID_8663 0.232 0.011 CID_7005 | CID_8663 | |
| 0.302 | 0.093 | 0.475 | Transcription factor NF kappa B inhibitor | 0.273 0.111 CID_108063 0.475 0.048 CID_11318 0.44 0.055 CID_8663 0.425 0.058 CID_7005 | CID_11318 | |
| 0.216 | 0.006 | 0.256 | Prolactin inhibitor | 0.152 0.021 CID_108063 0.244 0.004 CID_11318 0.256 0.004 CID_8663 0.233 0.005 CID_7005 | CID_8663 | |
| 0.247 | 0.039 | 0.247 | I kappa B kinase epsilon inhibitor | 0.199 0.071 CID_11318 0.221 0.055 CID_8663 0.217 0.058 CID_7005 | ||
| 0.214 | 0.008 | 0.22 | Papain-like protease (SARS coronavirus) inhibitor | 0.122 0.076 CID_108063 0.183 0.015 CID_11318 0.22 0.007 CID_8663 0.169 0.021 CID_7005 | CID_8663 | |
| 0.233 | 0.029 | 0.31 | Phospholipase C inhibitor | 0.15 0.107 CID_108063 0.305 0.018 CID_11318 0.31 0.017 CID_8663 0.285 0.02 CID_7005 | CID_8663 | |
| 0.23 | 0.026 | 0.334 | NADPH oxidase inhibitor | 0.334 0.009 CID_11318 0.313 0.011 CID_8663 0.296 0.013 CID_7005 | CID_11318 | |
| 0.208 | 0.005 | 0.208 | Biliverdin reductase inhibitor | 0.088 0.023 CID_108063 0.111 0.016 CID_11318 0.128 0.012 CID_8663 0.128 0.012 CID_7005 | ||
| 0.21 | 0.007 | 0.21 | Electrolyte absorption antagonist | 0.1 0.058 CID_108063 0.129 0.03 CID_11318 0.152 0.019 CID_8663 0.145 0.021 CID_7005 | ||
| 0.216 | 0.014 | 0.336 | Carbonic anhydrase III inhibitor | 0.106 0.056 CID_108063 0.336 0.005 CID_11318 0.328 0.005 CID_8663 0.3 0.005 CID_7005 | CID_11318 | |
| 0.207 | 0.005 | 0.285 | DOPA decarboxylase inhibitor | 0.124 0.041 CID_108063 0.277 0.003 CID_11318 0.285 0.003 CID_8663 0.259 0.003 CID_7005 | CID_8663 | |
| 0.256 | 0.055 | 0.256 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.21 | 0.01 | 0.234 | Adenylate cyclase stimulant | 0.167 0.038 CID_108063 0.218 0.008 CID_11318 0.234 0.005 CID_8663 0.209 0.01 CID_7005 | CID_8663 | |
| 0.252 | 0.054 | 0.252 | Clk dual-specificity kinase inhibitor | |||
| 0.211 | 0.013 | 0.211 | Catalase inhibitor | 0.074 0.052 CID_108063 0.172 0.021 CID_11318 0.182 0.019 CID_8663 0.192 0.017 CID_7005 | ||
| 0.202 | 0.005 | 0.202 | Glutamate release inhibitor | 0.133 0.015 CID_108063 0.149 0.01 CID_11318 0.168 0.007 CID_8663 0.169 0.006 CID_7005 | ||
| 0.232 | 0.034 | 0.232 | Cytidine deaminase inhibitor | 0.139 0.084 CID_11318 0.163 0.067 CID_8663 0.164 0.066 CID_7005 | ||
| 0.291 | 0.094 | 0.319 | Antithrombotic | 0.268 0.112 CID_108063 0.319 0.077 CID_11318 0.305 0.084 CID_8663 0.297 0.09 CID_7005 | CID_11318 | |
| 0.256 | 0.059 | 0.256 | Calpain inhibitor | 0.215 0.1 CID_11318 0.227 0.087 CID_8663 0.232 0.082 CID_7005 | ||
| 0.216 | 0.019 | 0.216 | Cathepsin H inhibitor | 0.151 0.046 CID_108063 0.144 0.051 CID_11318 0.17 0.034 CID_8663 0.158 0.04 CID_7005 | ||
| 0.259 | 0.064 | 0.368 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.368 0.032 CID_11318 0.359 0.034 CID_8663 0.317 0.045 CID_7005 | CID_11318 | |
| 0.21 | 0.014 | 0.21 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.177 0.035 CID_11318 0.169 0.044 CID_8663 0.192 0.023 CID_7005 | ||
| 0.196 | 0.004 | 0.196 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 CID_108063 0.19 0.004 CID_11318 0.187 0.005 CID_8663 0.195 0.004 CID_7005 | ||
| 0.195 | 0.003 | 0.195 | Aconitate hydratase inhibitor | 0.087 0.011 CID_108063 0.112 0.007 CID_11318 0.127 0.005 CID_8663 0.127 0.005 CID_7005 | ||
| 0.202 | 0.01 | 0.202 | Sphingosine 1-phosphate receptor 5 antagonist | 0.183 0.021 CID_11318 0.193 0.015 CID_8663 0.183 0.021 CID_7005 | ||
| 0.21 | 0.019 | 0.268 | Toll-Like receptor 2 antagonist | 0.119 0.078 CID_108063 0.264 0.007 CID_11318 0.268 0.007 CID_8663 0.237 0.012 CID_7005 | CID_8663 | |
| 0.199 | 0.011 | 0.233 | TRPA1 agonist | 0.098 0.092 CID_108063 0.167 0.021 CID_11318 0.233 0.006 CID_8663 0.201 0.01 CID_7005 | CID_8663 | |
| 0.224 | 0.04 | 0.235 | Tumour necrosis factor antagonist | 0.152 0.099 CID_108063 0.21 0.048 CID_11318 0.235 0.036 CID_8663 0.222 0.041 CID_7005 | CID_8663 | |
| 0.254 | 0.07 | 0.336 | Dyrk kinase inhibitor | 0.334 0.041 CID_11318 0.336 0.041 CID_8663 0.288 0.057 CID_7005 | CID_8663 | |
| 0.196 | 0.013 | 0.299 | Alcohol dehydrogenase inhibitor | 0.198 0.013 CID_11318 0.299 0.005 CID_8663 0.261 0.007 CID_7005 | CID_8663 | |
| 0.231 | 0.048 | 0.231 | LIM domain kinase 1 inhibitor | 0.155 0.093 CID_11318 0.193 0.066 CID_8663 0.19 0.068 CID_7005 | ||
| 0.212 | 0.029 | 0.252 | Neurotensin receptor agonist | 0.196 0.036 CID_11318 0.252 0.021 CID_8663 0.236 0.023 CID_7005 | CID_8663 | |
| 0.236 | 0.053 | 0.319 | DNA methyltransferase I inhibitor | 0.319 0.02 CID_11318 0.291 0.029 CID_8663 0.292 0.029 CID_7005 | CID_11318 | |
| 0.266 | 0.084 | 0.326 | Spasmolytic | 0.202 0.118 CID_108063 0.326 0.06 CID_11318 0.309 0.067 CID_8663 0.297 0.071 CID_7005 | CID_11318 | |
| 0.193 | 0.012 | 0.193 | Phosphofructokinase-1 inhibitor | 0.131 0.022 CID_108063 0.157 0.017 CID_11318 0.174 0.014 CID_8663 0.174 0.014 CID_7005 | ||
| 0.2 | 0.019 | 0.2 | Interleukin 1b antagonist | 0.167 0.03 CID_11318 0.101 0.08 CID_8663 0.121 0.062 CID_7005 | ||
| 0.192 | 0.011 | 0.199 | Sphingomyelinase inhibitor | 0.199 0.01 CID_108063 0.136 0.031 CID_11318 0.158 0.021 CID_8663 0.175 0.016 CID_7005 | CID_108063 | |
| 0.209 | 0.029 | 0.209 | Interleukin 1 antagonist | 0.197 0.034 CID_11318 0.137 0.069 CID_8663 0.151 0.057 CID_7005 | ||
| 0.184 | 0.004 | 0.187 | Granulocyte macrophage colony stimulating factor agonist | 0.114 0.02 CID_108063 0.178 0.004 CID_11318 0.187 0.003 CID_8663 0.168 0.004 CID_7005 | CID_8663 | |
| 0.215 | 0.036 | 0.273 | Protein kinase stimulant | 0.214 0.037 CID_108063 0.247 0.027 CID_11318 0.273 0.021 CID_8663 0.232 0.031 CID_7005 | CID_8663 | |
| 0.189 | 0.011 | 0.189 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.033 CID_11318 0.17 0.019 CID_8663 0.166 0.022 CID_7005 | ||
| 0.185 | 0.008 | 0.236 | Glutamate decarboxylase inhibitor | 0.087 0.038 CID_108063 0.236 0.005 CID_11318 0.227 0.005 CID_8663 0.215 0.006 CID_7005 | CID_11318 | |
| 0.212 | 0.036 | 0.364 | Melanin inhibitor | 0.158 0.072 CID_108063 0.336 0.018 CID_11318 0.364 0.015 CID_8663 0.364 0.015 CID_7005 | CID_7005 | |
| 0.194 | 0.02 | 0.194 | Falcipain 3 inhibitor | 0.152 0.035 CID_11318 0.162 0.031 CID_8663 0.144 0.039 CID_7005 | ||
| 0.211 | 0.037 | 0.287 | Interferon gamma antagonist | 0.257 0.027 CID_108063 0.287 0.022 CID_11318 0.284 0.022 CID_8663 0.261 0.026 CID_7005 | CID_11318 | |
| 0.276 | 0.102 | 0.398 | Sodium/bile acid cotransporter inhibitor | 0.365 0.031 CID_11318 0.398 0.018 CID_8663 0.384 0.022 CID_7005 | CID_8663 | |
| 0.225 | 0.051 | 0.266 | Insulin sensitizer | 0.173 0.104 CID_108063 0.266 0.026 CID_11318 0.244 0.038 CID_8663 0.249 0.035 CID_7005 | CID_11318 | |
| 0.218 | 0.045 | 0.218 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.124 0.097 CID_11318 0.137 0.087 CID_8663 0.129 0.093 CID_7005 | ||
| 0.183 | 0.01 | 0.198 | Heat shock protein 70 antagonist | 0.136 0.089 CID_108063 0.18 0.012 CID_11318 0.198 0.007 CID_8663 0.185 0.01 CID_7005 | CID_8663 | |
| 0.195 | 0.022 | 0.195 | Aminopeptidase B inhibitor | 0.102 0.063 CID_108063 0.155 0.036 CID_11318 0.181 0.026 CID_8663 0.168 0.031 CID_7005 | ||
| 0.179 | 0.006 | 0.179 | Acetylcholine release stimulant | 0.103 0.081 CID_108063 0.129 0.035 CID_11318 0.142 0.022 CID_8663 0.141 0.023 CID_7005 | ||
| 0.231 | 0.059 | 0.308 | DNA methylase inhibitor | 0.308 0.025 CID_11318 0.276 0.036 CID_8663 0.278 0.035 CID_7005 | CID_11318 | |
| 0.228 | 0.057 | 0.228 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.166 0.105 CID_8663 0.136 0.133 CID_7005 | ||
| 0.201 | 0.03 | 0.213 | Cell wall synthesis inhibitor | 0.203 0.029 CID_11318 0.201 0.029 CID_8663 0.213 0.025 CID_7005 | CID_7005 | |
| 0.186 | 0.015 | 0.186 | Pregnane X receptor agonist | 0.147 0.058 CID_108063 0.157 0.041 CID_11318 0.178 0.02 CID_8663 0.158 0.04 CID_7005 | ||
| 0.178 | 0.007 | 0.178 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.096 0.015 CID_108063 0.109 0.013 CID_11318 0.122 0.011 CID_8663 0.122 0.011 CID_7005 | ||
| 0.176 | 0.006 | 0.176 | Lanosterol 14 alpha demethylase inhibitor | 0.112 0.039 CID_108063 0.128 0.024 CID_11318 0.161 0.008 CID_8663 0.14 0.016 CID_7005 | ||
| 0.222 | 0.053 | 0.222 | Focal adhesion kinase 2 inhibitor | 0.159 0.117 CID_8663 0.171 0.099 CID_7005 | ||
| 0.207 | 0.039 | 0.207 | Cyclooxygenase inhibitor | 0.181 0.05 CID_11318 0.194 0.044 CID_8663 0.203 0.041 CID_7005 | ||
| 0.184 | 0.018 | 0.203 | Interleukin 8 antagonist | 0.194 0.014 CID_11318 0.203 0.012 CID_8663 0.165 0.026 CID_7005 | CID_8663 | |
| 0.183 | 0.018 | 0.209 | Protein kinase C gamma inhibitor | 0.209 0.012 CID_11318 0.203 0.013 CID_8663 0.177 0.02 CID_7005 | CID_11318 | |
| 0.198 | 0.033 | 0.264 | Catenin beta inhibitor | 0.264 0.009 CID_11318 0.223 0.019 CID_8663 0.234 0.015 CID_7005 | CID_11318 | |
| 0.176 | 0.012 | 0.176 | Glutamate dehydrogenase inhibitor | 0.097 0.032 CID_108063 0.128 0.02 CID_11318 0.143 0.017 CID_8663 0.166 0.013 CID_7005 | ||
| 0.171 | 0.007 | 0.171 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 CID_108063 0.09 0.019 CID_11318 0.104 0.015 CID_8663 0.104 0.015 CID_7005 | ||
| 0.198 | 0.035 | 0.198 | Nav1.2 sodium channel blocker | 0.168 0.047 CID_108063 0.109 0.097 CID_11318 0.144 0.061 CID_8663 0.162 0.051 CID_7005 | ||
| 0.197 | 0.036 | 0.204 | Death-associated protein kinase 2 inhibitor | 0.198 0.036 CID_11318 0.204 0.031 CID_8663 0.156 0.093 CID_7005 | CID_8663 | |
| 0.297 | 0.138 | 0.448 | Antibacterial | 0.448 0.057 CID_108063 0.404 0.075 CID_11318 0.342 0.106 CID_8663 0.395 0.079 CID_7005 | CID_108063 | |
| 0.184 | 0.025 | 0.21 | Cyclooxygenase 3 inhibitor | 0.122 0.075 CID_108063 0.188 0.023 CID_11318 0.21 0.015 CID_8663 0.205 0.017 CID_7005 | CID_8663 | |
| 0.166 | 0.01 | 0.166 | Carbamoyl phosphate synthetase inhibitor | 0.091 0.024 CID_108063 0.115 0.017 CID_11318 0.128 0.014 CID_8663 0.128 0.014 CID_7005 | ||
| 0.165 | 0.008 | 0.165 | Glutamate (mGluR7) agonist | 0.099 0.061 CID_108063 0.101 0.058 CID_11318 0.11 0.042 CID_8663 0.11 0.042 CID_7005 | ||
| 0.165 | 0.01 | 0.165 | Histamine N-methyltransferase inhibitor | 0.079 0.068 CID_108063 0.131 0.023 CID_11318 0.155 0.012 CID_8663 0.143 0.017 CID_7005 | ||
| 0.194 | 0.039 | 0.194 | Cyclin-dependent kinase 8 inhibitor | 0.135 0.096 CID_11318 0.157 0.073 CID_8663 0.159 0.071 CID_7005 | ||
| 0.173 | 0.019 | 0.173 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.037 CID_11318 0.163 0.027 CID_8663 0.152 0.039 CID_7005 | ||
| 0.219 | 0.065 | 0.219 | Death-associated protein kinase 3 inhibitor | 0.145 0.13 CID_8663 | ||
| 0.17 | 0.017 | 0.265 | Carbonic anhydrase VI inhibitor | 0.071 0.07 CID_108063 0.257 0.008 CID_11318 0.265 0.008 CID_8663 0.225 0.01 CID_7005 | CID_8663 | |
| 0.184 | 0.031 | 0.233 | Cholesterol synthesis inhibitor | 0.151 0.044 CID_108063 0.214 0.024 CID_11318 0.233 0.02 CID_8663 0.23 0.021 CID_7005 | CID_8663 | |
| 0.171 | 0.018 | 0.171 | Calcium antagonist | 0.074 0.069 CID_11318 0.093 0.053 CID_8663 0.108 0.042 CID_7005 | ||
| 0.17 | 0.018 | 0.181 | DNA repair enzyme inhibitor | 0.174 0.016 CID_11318 0.164 0.021 CID_8663 0.181 0.013 CID_7005 | CID_7005 | |
| 0.162 | 0.01 | 0.162 | Argininosuccinate synthase inhibitor | 0.064 0.034 CID_108063 0.097 0.02 CID_11318 0.114 0.016 CID_8663 0.114 0.016 CID_7005 | ||
| 0.19 | 0.038 | 0.233 | Cyclooxygenase 1 inhibitor | 0.202 0.033 CID_11318 0.233 0.024 CID_8663 0.23 0.025 CID_7005 | CID_8663 | |
| 0.172 | 0.021 | 0.282 | Potassium channel (Ca-activated) activator | 0.202 0.014 CID_11318 0.207 0.013 CID_8663 0.282 0.005 CID_7005 | CID_7005 | |
| 0.25 | 0.1 | 0.476 | Lipoxygenase inhibitor | 0.18 0.163 CID_108063 0.476 0.022 CID_11318 0.402 0.037 CID_8663 0.432 0.03 CID_7005 | CID_11318 | |
| 0.184 | 0.036 | 0.184 | Cyclooxygenase 2 inhibitor | 0.144 0.058 CID_11318 0.149 0.054 CID_8663 0.16 0.047 CID_7005 | ||
| 0.192 | 0.045 | 0.192 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.311 | 0.164 | 0.733 | Apoptosis agonist | 0.733 0.025 CID_108063 0.687 0.033 CID_11318 0.524 0.067 CID_8663 0.598 0.049 CID_7005 | CID_108063 | |
| 0.153 | 0.007 | 0.153 | Glycine receptor antagonist | 0.133 0.012 CID_108063 0.11 0.024 CID_11318 0.131 0.013 CID_8663 0.132 0.012 CID_7005 | ||
| 0.152 | 0.007 | 0.152 | Glycine receptor agonist | 0.102 0.02 CID_108063 0.116 0.014 CID_11318 0.131 0.01 CID_8663 0.131 0.01 CID_7005 | ||
| 0.194 | 0.049 | 0.203 | Protein kinase C nu inhibitor | 0.203 0.046 CID_11318 | CID_11318 | |
| 0.161 | 0.016 | 0.176 | Transcription factor STAT6 inhibitor | 0.151 0.022 CID_11318 0.169 0.013 CID_8663 0.176 0.011 CID_7005 | CID_7005 | |
| 0.175 | 0.032 | 0.216 | Adenylate cyclase inhibitor | 0.216 0.023 CID_11318 0.209 0.024 CID_8663 0.208 0.024 CID_7005 | CID_11318 | |
| 0.195 | 0.052 | 0.314 | Heat shock protein 90 alpha antagonist | 0.22 0.039 CID_108063 0.281 0.018 CID_11318 0.258 0.024 CID_8663 0.314 0.012 CID_7005 | CID_7005 | |
| 0.167 | 0.024 | 0.189 | Mucolytic | 0.111 0.063 CID_108063 0.177 0.02 CID_11318 0.189 0.016 CID_8663 0.177 0.02 CID_7005 | CID_8663 | |
| 0.187 | 0.045 | 0.187 | Thiol protease inhibitor | 0.179 0.049 CID_11318 0.146 0.073 CID_8663 0.163 0.058 CID_7005 | ||
| 0.175 | 0.034 | 0.175 | Nav1.3 sodium channel blocker | 0.143 0.053 CID_108063 0.117 0.077 CID_8663 0.136 0.059 CID_7005 | ||
| 0.17 | 0.029 | 0.186 | Beta amyloid protein antagonist | 0.186 0.022 CID_108063 0.119 0.068 CID_11318 0.15 0.041 CID_8663 0.131 0.056 CID_7005 | CID_108063 | |
| 0.157 | 0.017 | 0.276 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 CID_108063 0.22 0.008 CID_11318 0.242 0.006 CID_8663 0.276 0.005 CID_7005 | CID_7005 | |
| 0.148 | 0.009 | 0.148 | Sphingosine 1-phosphate receptor 4 agonist | 0.089 0.031 CID_11318 0.136 0.012 CID_8663 0.108 0.022 CID_7005 | ||
| 0.182 | 0.044 | 0.182 | Toll-Like receptor 9 antagonist | 0.11 0.098 CID_11318 0.152 0.061 CID_8663 0.123 0.083 CID_7005 | ||
| 0.148 | 0.009 | 0.148 | Bromodomain-containing protein 2 inhibitor | 0.118 0.024 CID_11318 0.112 0.028 CID_8663 0.109 0.031 CID_7005 | ||
| 0.144 | 0.006 | 0.199 | D-Ala-D-Ala ligase inhibitor | 0.09 0.044 CID_108063 0.168 0.004 CID_11318 0.199 0.003 CID_8663 0.183 0.004 CID_7005 | CID_8663 | |
| 0.153 | 0.016 | 0.168 | Anabolic | 0.113 0.046 CID_108063 0.156 0.015 CID_11318 0.168 0.01 CID_8663 0.159 0.014 CID_7005 | CID_8663 | |
| 0.201 | 0.066 | 0.201 | CDC-like kinase 2 inhibitor | |||
| 0.148 | 0.013 | 0.148 | Aminopeptidase I inhibitor | 0.083 0.039 CID_108063 0.108 0.024 CID_11318 0.129 0.017 CID_8663 0.117 0.02 CID_7005 | ||
| 0.185 | 0.05 | 0.185 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.142 | 0.008 | 0.156 | Purinergic P2X1 antagonist | 0.075 0.028 CID_108063 0.144 0.008 CID_11318 0.145 0.008 CID_8663 0.156 0.006 CID_7005 | CID_7005 | |
| 0.164 | 0.031 | 0.234 | Microtubule formation inhibitor | 0.234 0.013 CID_108063 0.152 0.037 CID_11318 0.158 0.034 CID_8663 0.146 0.039 CID_7005 | CID_108063 | |
| 0.174 | 0.04 | 0.174 | Sodium channel (voltage-gated) blocker | 0.118 0.087 CID_8663 0.134 0.069 CID_7005 | ||
| 0.188 | 0.055 | 0.188 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.173 | 0.04 | 0.173 | MAP kinase 3 inhibitor | 0.133 0.099 CID_11318 0.139 0.086 CID_8663 0.142 0.08 CID_7005 | ||
| 0.136 | 0.004 | 0.136 | Glutamate (mGluR7) antagonist | 0.105 0.008 CID_108063 0.106 0.008 CID_11318 0.13 0.004 CID_8663 0.115 0.005 CID_7005 | ||
| 0.135 | 0.004 | 0.135 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.022 CID_108063 0.094 0.018 CID_11318 0.105 0.01 CID_8663 0.1 0.013 CID_7005 | ||
| 0.141 | 0.01 | 0.157 | Carbonic anhydrase VB inhibitor | 0.126 0.012 CID_11318 0.157 0.008 CID_8663 0.129 0.011 CID_7005 | CID_8663 | |
| 0.183 | 0.052 | 0.183 | Diuretic | 0.156 0.073 CID_11318 0.168 0.062 CID_8663 0.157 0.071 CID_7005 | ||
| 0.135 | 0.004 | 0.135 | Phospholipase D inhibitor | 0.096 0.017 CID_108063 0.095 0.018 CID_11318 0.106 0.012 CID_8663 0.113 0.009 CID_7005 | ||
| 0.135 | 0.004 | 0.135 | Glutamate (mGluR6) antagonist | 0.093 0.014 CID_108063 0.097 0.012 CID_11318 0.105 0.009 CID_8663 0.105 0.009 CID_7005 | ||
| 0.139 | 0.01 | 0.197 | GABA aminotransferase inhibitor | 0.197 0.004 CID_11318 0.152 0.008 CID_8663 0.153 0.007 CID_7005 | CID_11318 | |
| 0.151 | 0.022 | 0.227 | Carbonic anhydrase XIII inhibitor | 0.222 0.011 CID_11318 0.227 0.011 CID_8663 0.184 0.016 CID_7005 | CID_8663 | |
| 0.207 | 0.078 | 0.207 | Anticonvulsant | |||
| 0.16 | 0.031 | 0.16 | GABA receptor agonist | 0.101 0.076 CID_11318 0.121 0.055 CID_8663 0.118 0.059 CID_7005 | ||
| 0.177 | 0.049 | 0.177 | Activin receptor-like kinase 2 inhibitor | 0.123 0.093 CID_11318 0.156 0.062 CID_8663 0.144 0.072 CID_7005 | ||
| 0.143 | 0.015 | 0.234 | Keratolytic | 0.179 0.01 CID_11318 0.234 0.006 CID_8663 0.208 0.008 CID_7005 | CID_8663 | |
| 0.181 | 0.054 | 0.427 | Interleukin 6 antagonist | 0.427 0.006 CID_108063 0.316 0.013 CID_11318 0.2 0.041 CID_8663 0.208 0.036 CID_7005 | CID_108063 | |
| 0.195 | 0.068 | 0.195 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.238 | 0.111 | 0.438 | Streptokinase A inhibitor | 0.321 0.071 CID_11318 0.327 0.069 CID_8663 0.438 0.038 CID_7005 | CID_7005 | |
| 0.138 | 0.011 | 0.138 | Nicotinic alpha4beta2 receptor antagonist | 0.077 0.053 CID_11318 0.101 0.03 CID_8663 0.087 0.043 CID_7005 | ||
| 0.134 | 0.007 | 0.134 | Acetylcholine M5 receptor agonist | 0.079 0.035 CID_108063 0.071 0.043 CID_11318 0.096 0.022 CID_8663 0.084 0.031 CID_7005 | ||
| 0.13 | 0.004 | 0.13 | Exportin-1 inhibitor | 0.105 0.007 CID_108063 0.081 0.024 CID_11318 0.095 0.012 CID_8663 0.089 0.016 CID_7005 | ||
| 0.165 | 0.039 | 0.216 | MAP kinase kinase 4 inhibitor | 0.154 0.054 CID_11318 0.216 0.009 CID_8663 0.191 0.018 CID_7005 | CID_8663 | |
| 0.168 | 0.042 | 0.168 | Anesthetic local | 0.158 0.045 CID_11318 0.126 0.063 CID_8663 0.13 0.06 CID_7005 | ||
| 0.251 | 0.126 | 0.382 | Prostaglandin dehydrogenase inhibitor | 0.382 0.072 CID_11318 0.277 0.113 CID_8663 0.335 0.088 CID_7005 | CID_11318 | |
| 0.13 | 0.005 | 0.13 | Potassium channel intermediate-conductance Ca-activated blocker | 0.066 0.031 CID_11318 0.071 0.026 CID_8663 0.076 0.02 CID_7005 | ||
| 0.142 | 0.017 | 0.313 | Macrophage migration inhibitory factor inhibitor | 0.202 0.008 CID_11318 0.313 0.004 CID_8663 0.175 0.01 CID_7005 | CID_8663 | |
| 0.177 | 0.053 | 0.177 | Protein kinase (CK1) gamma inhibitor | |||
| 0.129 | 0.005 | 0.154 | GABA B receptor agonist | 0.072 0.063 CID_108063 0.154 0.004 CID_11318 0.15 0.004 CID_8663 0.143 0.005 CID_7005 | CID_11318 | |
| 0.155 | 0.031 | 0.253 | Nav1.1 sodium channel blocker | 0.253 0.012 CID_108063 0.129 0.042 CID_8663 0.157 0.03 CID_7005 | CID_108063 | |
| 0.144 | 0.021 | 0.209 | Protein kinase C zeta inhibitor | 0.204 0.011 CID_11318 0.209 0.01 CID_8663 0.181 0.014 CID_7005 | CID_8663 | |
| 0.15 | 0.027 | 0.15 | Nav1.5 sodium channel blocker | 0.101 0.084 CID_11318 0.111 0.066 CID_8663 0.115 0.061 CID_7005 | ||
| 0.134 | 0.012 | 0.134 | mTOR complex 2 inhibitor | 0.108 0.025 CID_108063 0.106 0.027 CID_11318 0.117 0.019 CID_8663 0.107 0.026 CID_7005 | ||
| 0.125 | 0.003 | 0.224 | Dopamine D5 agonist | 0.053 0.016 CID_108063 0.212 0.002 CID_11318 0.224 0.002 CID_8663 0.154 0.003 CID_7005 | CID_8663 | |
| 0.17 | 0.049 | 0.17 | Cytokine production inhibitor | 0.132 0.078 CID_11318 0.143 0.068 CID_8663 0.158 0.056 CID_7005 | ||
| 0.138 | 0.017 | 0.154 | Carbonic anhydrase V inhibitor | 0.124 0.02 CID_11318 0.154 0.014 CID_8663 0.13 0.019 CID_7005 | CID_8663 | |
| 0.128 | 0.007 | 0.172 | Estrogen-related receptor beta agonist | 0.089 0.044 CID_108063 0.133 0.006 CID_11318 0.172 0.003 CID_8663 0.142 0.005 CID_7005 | CID_8663 | |
| 0.134 | 0.014 | 0.153 | Myeloperoxidase inhibitor | 0.144 0.012 CID_11318 0.153 0.01 CID_8663 0.131 0.015 CID_7005 | CID_8663 | |
| 0.169 | 0.049 | 0.201 | Hemostatic | 0.201 0.032 CID_11318 0.165 0.052 CID_8663 0.189 0.037 CID_7005 | CID_11318 | |
| 0.149 | 0.029 | 0.149 | Activin receptor-like kinase 4 inhibitor | |||
| 0.126 | 0.007 | 0.242 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.041 CID_108063 0.166 0.004 CID_11318 0.242 0.003 CID_8663 0.232 0.003 CID_7005 | CID_8663 | |
| 0.168 | 0.049 | 0.204 | Alkaline phosphatase inhibitor | 0.19 0.037 CID_11318 0.204 0.031 CID_8663 0.203 0.032 CID_7005 | CID_8663 | |
| 0.153 | 0.035 | 0.173 | Vanilloid 1 agonist | 0.167 0.025 CID_11318 0.167 0.025 CID_8663 0.173 0.022 CID_7005 | CID_7005 | |
| 0.147 | 0.03 | 0.21 | AMP-activated protein kinase stimulant | 0.21 0.01 CID_11318 0.168 0.018 CID_8663 0.205 0.01 CID_7005 | CID_11318 | |
| 0.139 | 0.023 | 0.139 | Interleukin 1 beta converting enzyme inhibitor | 0.136 0.024 CID_11318 0.134 0.025 CID_8663 0.129 0.029 CID_7005 | ||
| 0.123 | 0.007 | 0.142 | CC chemokine 5 receptor agonist | 0.078 0.072 CID_108063 0.104 0.017 CID_11318 0.142 0.004 CID_8663 0.112 0.012 CID_7005 | CID_8663 | |
| 0.121 | 0.006 | 0.121 | Vanilloid 4 agonist | 0.08 0.041 CID_108063 0.085 0.032 CID_11318 0.092 0.024 CID_8663 0.101 0.016 CID_7005 | ||
| 0.156 | 0.041 | 0.179 | Antibacterial (Helicobacter pylori) | 0.179 0.029 CID_11318 0.143 0.053 CID_8663 0.165 0.036 CID_7005 | CID_11318 | |
| 0.137 | 0.022 | 0.137 | MAP kinase kinase 1 inhibitor | 0.096 0.062 CID_108063 0.124 0.032 CID_11318 0.124 0.031 CID_8663 0.137 0.022 CID_7005 | ||
| 0.172 | 0.057 | 0.172 | Acetylcholine M1 receptor antagonist | 0.154 0.071 CID_11318 0.16 0.066 CID_8663 0.141 0.084 CID_7005 | ||
| 0.162 | 0.048 | 0.166 | Neuropeptide Y1 antagonist | 0.126 0.11 CID_11318 0.166 0.043 CID_8663 0.14 0.081 CID_7005 | CID_8663 | |
| 0.17 | 0.056 | 0.292 | Heat shock protein 90 antagonist | 0.21 0.033 CID_108063 0.27 0.015 CID_11318 0.253 0.02 CID_8663 0.292 0.011 CID_7005 | CID_7005 | |
| 0.131 | 0.017 | 0.135 | Phosphodiesterase 6D inhibitor | 0.12 0.024 CID_11318 0.135 0.015 CID_8663 0.134 0.016 CID_7005 | CID_8663 | |
| 0.122 | 0.008 | 0.122 | 5 Hydroxytryptamine 3 agonist | 0.067 0.039 CID_11318 0.097 0.017 CID_8663 0.09 0.02 CID_7005 | ||
| 0.172 | 0.058 | 0.172 | Cyclin-dependent kinase 3 inhibitor | 0.137 0.131 CID_11318 0.172 0.058 CID_8663 0.155 0.085 CID_7005 | ||
| 0.116 | 0.003 | 0.116 | Alpha 1d adrenoreceptor agonist | 0.053 0.015 CID_108063 0.088 0.004 CID_11318 0.093 0.004 CID_8663 0.084 0.005 CID_7005 | ||
| 0.159 | 0.047 | 0.159 | MAP3K9 inhibitor | 0.158 0.049 CID_8663 0.137 0.082 CID_7005 | ||
| 0.15 | 0.039 | 0.161 | Alpha 2b adrenoreceptor antagonist | 0.136 0.046 CID_108063 0.161 0.034 CID_11318 0.133 0.048 CID_8663 0.139 0.045 CID_7005 | CID_11318 | |
| 0.178 | 0.067 | 0.178 | Antipruritic | 0.138 0.11 CID_11318 0.171 0.072 CID_8663 0.163 0.08 CID_7005 | ||
| 0.127 | 0.016 | 0.14 | Carbonic anhydrase VA inhibitor | 0.113 0.02 CID_11318 0.14 0.013 CID_8663 0.119 0.018 CID_7005 | CID_8663 | |
| 0.147 | 0.036 | 0.215 | Expectorant | 0.112 0.057 CID_108063 0.215 0.017 CID_11318 0.184 0.024 CID_8663 0.166 0.029 CID_7005 | CID_11318 | |
| 0.117 | 0.007 | 0.202 | Topoisomerase II beta inhibitor | 0.202 0.004 CID_11318 0.168 0.004 CID_8663 0.153 0.005 CID_7005 | CID_11318 | |
| 0.156 | 0.046 | 0.156 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.145 | 0.036 | 0.262 | Xanthine oxidase inhibitor | 0.262 0.011 CID_11318 0.241 0.013 CID_8663 0.231 0.014 CID_7005 | CID_11318 | |
| 0.139 | 0.03 | 0.156 | Urease inhibitor | 0.156 0.02 CID_11318 0.155 0.021 CID_8663 0.146 0.025 CID_7005 | CID_11318 | |
| 0.205 | 0.096 | 0.336 | Antiamyloidogenic | 0.285 0.057 CID_108063 0.336 0.042 CID_11318 0.298 0.052 CID_8663 0.297 0.052 CID_7005 | CID_11318 | |
| 0.154 | 0.045 | 0.2 | Alkylator | 0.148 0.047 CID_108063 0.189 0.029 CID_11318 0.174 0.035 CID_8663 0.2 0.026 CID_7005 | CID_7005 | |
| 0.139 | 0.031 | 0.213 | Beta glucuronidase inhibitor | 0.213 0.011 CID_11318 0.21 0.012 CID_8663 0.188 0.014 CID_7005 | CID_11318 | |
| 0.113 | 0.005 | 0.113 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.045 CID_108063 0.058 0.029 CID_11318 0.071 0.017 CID_8663 0.066 0.021 CID_7005 | ||
| 0.117 | 0.009 | 0.117 | NMDA receptor glycine site agonist | 0.076 0.032 CID_11318 0.093 0.02 CID_8663 0.1 0.016 CID_7005 | ||
| 0.137 | 0.029 | 0.137 | Nitric-oxide synthase inhibitor | 0.096 0.067 CID_11318 0.09 0.077 CID_8663 0.094 0.07 CID_7005 | ||
| 0.218 | 0.11 | 0.255 | Immunostimulant | 0.166 0.142 CID_108063 0.255 0.094 CID_11318 0.242 0.099 CID_8663 0.249 0.096 CID_7005 | CID_11318 | |
| 0.145 | 0.038 | 0.145 | MAP kinase 13 inhibitor | |||
| 0.141 | 0.035 | 0.158 | Caspase 3 inhibitor | 0.139 0.037 CID_11318 0.134 0.042 CID_8663 0.158 0.023 CID_7005 | CID_7005 | |
| 0.134 | 0.028 | 0.134 | Phosphodiesterase 7B inhibitor | |||
| 0.154 | 0.05 | 0.446 | M18 aspartyl aminopeptidase inhibitor | 0.446 0.004 CID_11318 0.351 0.008 CID_8663 0.333 0.009 CID_7005 | CID_11318 | |
| 0.106 | 0.004 | 0.106 | Adenylate cyclase 1 inhibitor | 0.054 0.022 CID_108063 0.077 0.009 CID_11318 0.097 0.004 CID_8663 0.087 0.005 CID_7005 | ||
| 0.116 | 0.014 | 0.116 | NMDA receptor agonist | 0.066 0.04 CID_11318 0.088 0.024 CID_8663 0.091 0.023 CID_7005 | ||
| 0.107 | 0.005 | 0.107 | Calcium channel P-type blocker | 0.067 0.035 CID_108063 0.081 0.014 CID_11318 0.086 0.01 CID_8663 0.089 0.009 CID_7005 | ||
| 0.206 | 0.104 | 0.37 | Tumour necrosis factor alpha release inhibitor | 0.37 0.033 CID_11318 0.238 0.08 CID_8663 0.232 0.084 CID_7005 | CID_11318 | |
| 0.105 | 0.004 | 0.105 | Glutamate (mGluR1a) agonist | 0.027 0.01 CID_11318 0.05 0.005 CID_8663 0.034 0.007 CID_7005 | ||
| 0.124 | 0.023 | 0.127 | Ornithine decarboxylase inhibitor | 0.077 0.071 CID_108063 0.118 0.027 CID_11318 0.125 0.022 CID_8663 0.127 0.021 CID_7005 | CID_7005 | |
| 0.116 | 0.016 | 0.116 | Caspase 7 inhibitor | 0.098 0.031 CID_11318 0.092 0.038 CID_8663 0.097 0.032 CID_7005 | ||
| 0.121 | 0.022 | 0.143 | Glutathione S-transferase inhibitor | 0.143 0.014 CID_11318 0.117 0.024 CID_8663 0.127 0.019 CID_7005 | CID_11318 | |
| 0.125 | 0.027 | 0.565 | Estrogen receptor beta antagonist | 0.124 0.027 CID_108063 0.325 0.005 CID_11318 0.565 0.003 CID_8663 0.39 0.004 CID_7005 | CID_8663 | |
| 0.103 | 0.005 | 0.103 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 CID_108063 0.081 0.008 CID_11318 0.088 0.007 CID_8663 0.088 0.007 CID_7005 | ||
| 0.154 | 0.056 | 0.154 | Sodium channel blocker | 0.127 0.077 CID_7005 | ||
| 0.145 | 0.047 | 0.145 | Death-associated protein kinase 1 inhibitor | 0.121 0.11 CID_7005 | ||
| 0.146 | 0.048 | 0.319 | Monophenol monooxygenase inhibitor | 0.087 0.086 CID_108063 0.319 0.016 CID_11318 0.293 0.019 CID_8663 0.294 0.018 CID_7005 | CID_11318 | |
| 0.106 | 0.009 | 0.132 | MAP kinase kinase 7 inhibitor | 0.074 0.067 CID_108063 0.112 0.006 CID_11318 0.132 0.003 CID_8663 0.124 0.004 CID_7005 | CID_8663 | |
| 0.151 | 0.055 | 0.174 | Toll-Like receptor antagonist | 0.174 0.041 CID_11318 0.146 0.058 CID_8663 0.112 0.098 CID_7005 | CID_11318 | |
| 0.102 | 0.006 | 0.102 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.036 CID_11318 0.061 0.043 CID_8663 0.073 0.024 CID_7005 | ||
| 0.154 | 0.058 | 0.239 | MAO inhibitor | 0.225 0.034 CID_11318 0.229 0.033 CID_8663 0.239 0.03 CID_7005 | CID_7005 | |
| 0.101 | 0.005 | 0.101 | DNA helicase inhibitor | 0.082 0.01 CID_11318 0.079 0.012 CID_8663 0.09 0.008 CID_7005 | ||
| 0.132 | 0.036 | 0.567 | Estrogen antagonist | 0.129 0.039 CID_108063 0.302 0.006 CID_11318 0.567 0.004 CID_8663 0.366 0.005 CID_7005 | CID_8663 | |
| 0.102 | 0.007 | 0.107 | Sphingosine kinase 2 inhibitor | 0.052 0.044 CID_108063 0.093 0.01 CID_11318 0.107 0.006 CID_8663 0.088 0.012 CID_7005 | CID_8663 | |
| 0.106 | 0.011 | 0.106 | Aryl hydrocarbon receptor antagonist | 0.085 0.022 CID_11318 0.092 0.017 CID_8663 0.105 0.011 CID_7005 | ||
| 0.12 | 0.025 | 0.12 | Inducible nitric-oxide synthase inhibitor | 0.093 0.044 CID_11318 0.087 0.051 CID_8663 0.089 0.049 CID_7005 | ||
| 0.16 | 0.065 | 0.198 | Phospholipase A2 inhibitor | 0.185 0.051 CID_11318 0.198 0.043 CID_8663 0.194 0.046 CID_7005 | CID_8663 | |
| 0.172 | 0.079 | 0.268 | Amyloid beta precursor protein antagonist | 0.268 0.026 CID_11318 0.221 0.045 CID_8663 0.217 0.047 CID_7005 | CID_11318 | |
| 0.12 | 0.026 | 0.12 | Acetylcholine nicotinic agonist | 0.077 0.061 CID_8663 | ||
| 0.167 | 0.075 | 0.197 | Growth hormone agonist | 0.124 0.115 CID_11318 0.197 0.06 CID_8663 0.15 0.087 CID_7005 | CID_8663 | |
| 0.136 | 0.043 | 0.443 | 5-Lipoxygenase inhibitor | 0.443 0.005 CID_11318 0.312 0.009 CID_8663 0.408 0.005 CID_7005 | CID_11318 | |
| 0.129 | 0.037 | 0.129 | Gastric antisecretory | 0.098 0.068 CID_8663 0.091 0.077 CID_7005 | ||
| 0.287 | 0.195 | 0.287 | MAP kinase 1 inhibitor | 0.26 0.222 CID_108063 0.247 0.237 CID_11318 0.253 0.229 CID_8663 0.243 0.242 CID_7005 | ||
| 0.132 | 0.041 | 0.142 | Alpha 2c adrenoreceptor antagonist | 0.142 0.036 CID_108063 0.136 0.039 CID_11318 0.122 0.048 CID_8663 0.12 0.049 CID_7005 | CID_108063 | |
| 0.142 | 0.051 | 0.142 | Proteasome inhibitor | 0.105 0.08 CID_108063 0.12 0.065 CID_11318 0.128 0.059 CID_8663 0.138 0.053 CID_7005 | ||
| 0.115 | 0.024 | 0.131 | Bile acid receptor antagonist | 0.116 0.024 CID_11318 0.131 0.012 CID_8663 0.115 0.024 CID_7005 | CID_8663 | |
| 0.098 | 0.008 | 0.098 | MDM2 inhibitor | 0.067 0.047 CID_108063 0.072 0.033 CID_11318 0.077 0.024 CID_8663 0.078 0.023 CID_7005 | ||
| 0.17 | 0.08 | 0.21 | Lipocortins synthesis antagonist | 0.21 0.05 CID_8663 0.135 0.13 CID_7005 | CID_8663 | |
| 0.156 | 0.066 | 0.156 | CDC-like kinase 1 inhibitor | 0.143 0.075 CID_8663 | ||
| 0.117 | 0.028 | 0.117 | Glutamate receptor agonist | |||
| 0.103 | 0.014 | 0.104 | Alpha 2 adrenoreceptor agonist | 0.084 0.021 CID_108063 0.104 0.013 CID_11318 0.087 0.02 CID_8663 0.084 0.022 CID_7005 | CID_11318 | |
| 0.097 | 0.008 | 0.104 | Transcription factor RelA inhibitor | 0.07 0.029 CID_108063 0.1 0.006 CID_11318 0.104 0.005 CID_8663 0.095 0.008 CID_7005 | CID_8663 | |
| 0.093 | 0.004 | 0.093 | Immunoglobulin Fc receptor antagonist | 0.059 0.027 CID_108063 0.067 0.014 CID_11318 0.085 0.005 CID_8663 0.072 0.01 CID_7005 | ||
| 0.105 | 0.016 | 0.105 | Secretase beta inhibitor | 0.068 0.053 CID_11318 0.082 0.034 CID_8663 0.073 0.045 CID_7005 | ||
| 0.135 | 0.046 | 0.242 | MAO A inhibitor | 0.242 0.022 CID_11318 0.226 0.024 CID_8663 0.242 0.022 CID_7005 | CID_7005 | |
| 0.094 | 0.005 | 0.101 | Dihydroorotate oxidase inhibitor | 0.101 0.005 CID_11318 0.09 0.007 CID_8663 0.098 0.005 CID_7005 | CID_11318 | |
| 0.11 | 0.022 | 0.11 | Interferon agonist | 0.073 0.064 CID_108063 0.084 0.045 CID_11318 0.092 0.036 CID_8663 0.094 0.034 CID_7005 | ||
| 0.144 | 0.056 | 0.314 | Interleukin 4 antagonist | 0.217 0.018 CID_11318 0.314 0.008 CID_8663 0.28 0.01 CID_7005 | CID_8663 | |
| 0.099 | 0.011 | 0.146 | Fatty acid synthase inhibitor | 0.071 0.025 CID_108063 0.146 0.005 CID_11318 0.117 0.007 CID_8663 0.133 0.005 CID_7005 | CID_11318 | |
| 0.1 | 0.013 | 0.106 | Protein kinase C beta inhibitor | 0.106 0.011 CID_11318 0.099 0.014 CID_8663 0.09 0.02 CID_7005 | CID_11318 | |
| 0.104 | 0.018 | 0.104 | Carbonic anhydrase stimulant | 0.065 0.035 CID_11318 0.072 0.03 CID_8663 0.073 0.029 CID_7005 | ||
| 0.092 | 0.007 | 0.106 | Squalene epoxidase inhibitor | 0.068 0.015 CID_108063 0.106 0.005 CID_11318 0.099 0.005 CID_8663 0.087 0.008 CID_7005 | CID_11318 | |
| 0.113 | 0.028 | 0.113 | GABA A receptor agonist | 0.083 0.058 CID_8663 0.085 0.054 CID_7005 | ||
| 0.107 | 0.023 | 0.177 | Thioredoxin reductase inhibitor | 0.177 0.006 CID_108063 0.126 0.015 CID_11318 0.099 0.03 CID_8663 0.114 0.019 CID_7005 | CID_108063 | |
| 0.096 | 0.011 | 0.096 | Potassium channel (Tandem pore domain) blocker | 0.071 0.059 CID_8663 | ||
| 0.09 | 0.007 | 0.09 | Glutamate (mGluR4) antagonist | 0.054 0.017 CID_11318 0.052 0.019 CID_8663 0.065 0.012 CID_7005 | ||
| 0.088 | 0.005 | 0.088 | Pregnane X receptor antagonist | 0.059 0.034 CID_108063 0.082 0.006 CID_11318 0.081 0.006 CID_8663 0.087 0.005 CID_7005 | ||
| 0.099 | 0.016 | 0.124 | NMDA 2C receptor antagonist | 0.072 0.031 CID_11318 0.124 0.01 CID_8663 0.098 0.017 CID_7005 | CID_8663 | |
| 0.112 | 0.029 | 0.112 | Cathepsin G inhibitor | 0.099 0.034 CID_11318 0.095 0.035 CID_8663 0.101 0.033 CID_7005 | ||
| 0.106 | 0.022 | 0.106 | Benzodiazepine agonist | |||
| 0.091 | 0.009 | 0.091 | 5 Hydroxytryptamine 7 agonist | 0.067 0.022 CID_11318 0.089 0.009 CID_8663 0.075 0.016 CID_7005 | ||
| 0.117 | 0.035 | 0.151 | Androgen antagonist | 0.091 0.054 CID_108063 0.115 0.036 CID_11318 0.151 0.022 CID_8663 0.13 0.029 CID_7005 | CID_8663 | |
| 0.098 | 0.016 | 0.098 | Protease 3C (Human rhinovirus) inhibitor | 0.07 0.037 CID_11318 0.078 0.029 CID_8663 0.084 0.024 CID_7005 | ||
| 0.117 | 0.035 | 0.117 | Potassium channel (Voltage-sensitive) activator | |||
| 0.097 | 0.016 | 0.097 | 5 Hydroxytryptamine 2A agonist | 0.057 0.05 CID_11318 0.094 0.017 CID_8663 0.083 0.024 CID_7005 | ||
| 0.086 | 0.005 | 0.086 | GABA uptake inhibitor | 0.035 0.034 CID_108063 0.063 0.009 CID_11318 0.068 0.007 CID_8663 0.073 0.006 CID_7005 | ||
| 0.107 | 0.026 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.084 0.046 CID_108063 0.108 0.025 CID_11318 0.108 0.025 CID_8663 0.104 0.028 CID_7005 | CID_8663 | |
| 0.139 | 0.058 | 0.152 | MAP kinase kinase inhibitor | 0.11 0.084 CID_11318 0.152 0.05 CID_8663 0.139 0.058 CID_7005 | CID_8663 | |
| 0.098 | 0.018 | 0.098 | TRPA1 antagonist | 0.062 0.041 CID_11318 0.081 0.025 CID_8663 0.095 0.019 CID_7005 | ||
| 0.087 | 0.006 | 0.087 | Glutamate (mGluR group III) antagonist | 0.054 0.017 CID_11318 0.059 0.014 CID_8663 0.064 0.011 CID_7005 | ||
| 0.091 | 0.011 | 0.091 | Glucosylceramidase inhibitor | 0.063 0.027 CID_108063 0.065 0.026 CID_11318 0.076 0.018 CID_8663 0.071 0.021 CID_7005 | ||
| 0.086 | 0.006 | 0.102 | Ryanodine receptor antagonist | 0.055 0.054 CID_108063 0.078 0.01 CID_11318 0.102 0.004 CID_8663 0.079 0.009 CID_7005 | CID_8663 | |
| 0.083 | 0.004 | 0.083 | Nerve growth factor antagonist | 0.04 0.036 CID_108063 0.062 0.008 CID_11318 0.066 0.007 CID_8663 0.06 0.009 CID_7005 | ||
| 0.085 | 0.006 | 0.085 | Fumarate hydratase inhibitor | 0.039 0.019 CID_108063 0.05 0.013 CID_11318 0.057 0.011 CID_8663 0.057 0.011 CID_7005 | ||
| 0.097 | 0.018 | 0.175 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.153 0.007 CID_11318 0.159 0.006 CID_8663 0.175 0.005 CID_7005 | CID_7005 | |
| 0.089 | 0.01 | 0.16 | CD45 antagonist | 0.14 0.006 CID_11318 0.16 0.005 CID_8663 0.146 0.006 CID_7005 | CID_8663 | |
| 0.13 | 0.052 | 0.234 | DNA intercalator | 0.234 0.018 CID_11318 0.145 0.045 CID_8663 0.22 0.021 CID_7005 | CID_11318 | |
| 0.085 | 0.008 | 0.085 | Dihydroorotase inhibitor | 0.075 0.01 CID_11318 0.072 0.011 CID_8663 0.07 0.011 CID_7005 | ||
| 0.147 | 0.069 | 0.155 | Glycogen synthase kinase-3 alpha inhibitor | 0.118 0.086 CID_11318 0.141 0.072 CID_8663 0.155 0.063 CID_7005 | CID_7005 | |
| 0.09 | 0.013 | 0.09 | Potassium channel (Ca-activated) blocker | |||
| 0.133 | 0.056 | 0.133 | MAP kinase 12 inhibitor | |||
| 0.113 | 0.036 | 0.145 | Thioredoxin inhibitor | 0.109 0.039 CID_11318 0.127 0.027 CID_8663 0.145 0.019 CID_7005 | CID_7005 | |
| 0.171 | 0.094 | 0.6 | Amyloid beta aggregation inhibitor | 0.6 0.008 CID_11318 0.493 0.015 CID_8663 0.512 0.013 CID_7005 | CID_11318 | |
| 0.102 | 0.026 | 0.252 | Estrogen receptor alpha antagonist | 0.092 0.033 CID_108063 0.206 0.008 CID_11318 0.252 0.006 CID_8663 0.229 0.007 CID_7005 | CID_8663 | |
| 0.086 | 0.01 | 0.086 | Potassium channel (Inward rectifier) blocker | 0.047 0.038 CID_8663 0.049 0.035 CID_7005 | ||
| 0.081 | 0.005 | 0.081 | Diamine oxidase inhibitor | 0.034 0.031 CID_11318 0.044 0.019 CID_8663 0.05 0.014 CID_7005 | ||
| 0.1 | 0.024 | 0.103 | Amidase inhibitor | 0.076 0.041 CID_11318 0.103 0.023 CID_8663 0.09 0.03 CID_7005 | CID_8663 | |
| 0.093 | 0.018 | 0.093 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 CID_11318 0.062 0.03 CID_8663 0.062 0.03 CID_7005 | ||
| 0.08 | 0.005 | 0.084 | Dopamine beta hydroxylase inhibitor | 0.076 0.006 CID_11318 0.084 0.005 CID_8663 0.071 0.007 CID_7005 | CID_8663 | |
| 0.112 | 0.037 | 0.112 | Potassium channel activator | 0.084 0.069 CID_11318 0.083 0.07 CID_8663 0.105 0.043 CID_7005 | ||
| 0.083 | 0.008 | 0.083 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 CID_108063 0.065 0.018 CID_11318 0.07 0.015 CID_8663 0.077 0.011 CID_7005 | ||
| 0.081 | 0.006 | 0.092 | Purinergic P2X4 antagonist | 0.063 0.013 CID_11318 0.092 0.005 CID_8663 0.072 0.009 CID_7005 | CID_8663 | |
| 0.225 | 0.151 | 0.352 | Apoptosis antagonist | 0.2 0.179 CID_108063 0.352 0.055 CID_11318 0.339 0.061 CID_8663 0.337 0.062 CID_7005 | CID_11318 | |
| 0.111 | 0.037 | 0.111 | Toll-Like receptor 3 antagonist | |||
| 0.079 | 0.005 | 0.079 | Geranyltranstransferase inhibitor | 0.051 0.022 CID_108063 0.076 0.005 CID_11318 0.067 0.009 CID_8663 0.07 0.008 CID_7005 | ||
| 0.09 | 0.017 | 0.09 | Interferon inducer | 0.065 0.043 CID_11318 0.071 0.033 CID_8663 0.072 0.032 CID_7005 | ||
| 0.086 | 0.013 | 0.086 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.041 CID_11318 0.083 0.015 CID_8663 0.064 0.032 CID_7005 | ||
| 0.118 | 0.045 | 0.118 | CDC-like kinase 3 inhibitor | |||
| 0.099 | 0.026 | 0.596 | T cell inhibitor | 0.596 0.003 CID_108063 0.127 0.013 CID_11318 0.127 0.013 CID_7005 | CID_108063 | |
| 0.086 | 0.013 | 0.088 | Sphingosine kinase inhibitor | 0.084 0.014 CID_11318 0.088 0.012 CID_8663 0.086 0.013 CID_7005 | CID_8663 | |
| 0.103 | 0.03 | 0.175 | NMDA 2 receptor antagonist | 0.083 0.042 CID_11318 0.175 0.012 CID_8663 0.114 0.026 CID_7005 | CID_8663 | |
| 0.097 | 0.024 | 0.097 | Nav1.7 sodium channel blocker | |||
| 0.086 | 0.014 | 0.086 | Cyclin D1 inhibitor | 0.063 0.038 CID_11318 0.079 0.019 CID_8663 0.081 0.017 CID_7005 | ||
| 0.082 | 0.01 | 0.082 | Aldosterone antagonist | 0.052 0.027 CID_8663 0.048 0.033 CID_7005 | ||
| 0.122 | 0.05 | 0.185 | MAO B inhibitor | 0.138 0.042 CID_11318 0.176 0.029 CID_8663 0.185 0.027 CID_7005 | CID_7005 | |
| 0.112 | 0.04 | 0.112 | Acetylcholine agonist | |||
| 0.077 | 0.005 | 0.077 | Cytokine production stimulant | 0.047 0.038 CID_11318 0.055 0.019 CID_8663 0.051 0.026 CID_7005 | ||
| 0.113 | 0.041 | 0.113 | Protein kinase C delta inhibitor | 0.079 0.078 CID_11318 0.082 0.073 CID_8663 | ||
| 0.082 | 0.01 | 0.082 | Alpha-mannosidase inhibitor | 0.061 0.026 CID_108063 0.064 0.023 CID_11318 0.073 0.015 CID_8663 0.069 0.017 CID_7005 | ||
| 0.075 | 0.004 | 0.078 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.032 CID_108063 0.072 0.004 CID_11318 0.078 0.004 CID_8663 0.078 0.004 CID_7005 | CID_7005 | |
| 0.078 | 0.008 | 0.078 | Potassium channel (Inward rectifier) activator | 0.049 0.039 CID_108063 0.046 0.044 CID_11318 0.051 0.033 CID_8663 0.057 0.024 CID_7005 | ||
| 0.075 | 0.005 | 0.075 | Glutamate (mGluR3) antagonist | 0.045 0.016 CID_11318 0.059 0.009 CID_8663 0.057 0.009 CID_7005 | ||
| 0.107 | 0.037 | 0.107 | Phosphodiesterase I inhibitor | 0.083 0.07 CID_11318 0.098 0.047 CID_8663 0.085 0.067 CID_7005 | ||
| 0.086 | 0.016 | 0.086 | Phosphodiesterase 1C inhibitor | 0.074 0.024 CID_11318 0.076 0.023 CID_8663 0.066 0.036 CID_7005 | ||
| 0.172 | 0.102 | 0.322 | Interleukin antagonist | 0.268 0.055 CID_11318 0.322 0.043 CID_8663 0.243 0.064 CID_7005 | CID_8663 | |
| 0.098 | 0.029 | 0.102 | Alpha adrenoreceptor agonist | 0.067 0.048 CID_108063 0.102 0.027 CID_11318 0.088 0.033 CID_8663 0.073 0.043 CID_7005 | CID_11318 | |
| 0.082 | 0.013 | 0.163 | NMDA receptor subunit 3B antagonist | 0.069 0.016 CID_11318 0.163 0.005 CID_8663 0.147 0.006 CID_7005 | CID_8663 | |
| 0.076 | 0.008 | 0.083 | Retinoid X alpha receptor agonist | 0.055 0.013 CID_11318 0.056 0.012 CID_8663 0.083 0.007 CID_7005 | CID_7005 | |
| 0.105 | 0.036 | 0.105 | Acetylcholine nicotinic antagonist | 0.091 0.045 CID_108063 0.079 0.056 CID_8663 | ||
| 0.146 | 0.077 | 0.165 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.165 0.062 CID_8663 | CID_8663 | |
| 0.076 | 0.008 | 0.076 | Histamine H2 receptor agonist | |||
| 0.072 | 0.004 | 0.072 | Guanylate cyclase inhibitor | 0.051 0.02 CID_108063 0.06 0.011 CID_11318 0.066 0.007 CID_8663 0.065 0.008 CID_7005 | ||
| 0.128 | 0.06 | 0.128 | Acetylcholine muscarinic antagonist | 0.101 0.089 CID_11318 0.118 0.069 CID_8663 0.101 0.089 CID_7005 | ||
| 0.188 | 0.12 | 0.197 | MAP-kinase-activated kinase 5 inhibitor | 0.197 0.107 CID_8663 0.185 0.124 CID_7005 | CID_8663 | |
| 0.075 | 0.008 | 0.075 | Potassium channel (ATP-sensitive) activator | 0.046 0.037 CID_108063 0.044 0.043 CID_11318 0.049 0.032 CID_8663 0.054 0.023 CID_7005 | ||
| 0.109 | 0.042 | 0.178 | NMDA receptor antagonist | 0.085 0.059 CID_11318 0.178 0.018 CID_8663 0.135 0.029 CID_7005 | CID_8663 | |
| 0.087 | 0.02 | 0.104 | Androgen agonist | 0.076 0.026 CID_11318 0.104 0.013 CID_8663 0.084 0.022 CID_7005 | CID_8663 | |
| 0.071 | 0.004 | 0.071 | Kainate receptor agonist | 0.048 0.017 CID_108063 0.055 0.01 CID_11318 0.059 0.007 CID_8663 0.059 0.007 CID_7005 | ||
| 0.124 | 0.058 | 0.124 | Calcium channel N-type blocker | |||
| 0.074 | 0.007 | 0.074 | GABA B receptor antagonist | 0.064 0.01 CID_11318 0.059 0.013 CID_8663 0.062 0.011 CID_7005 | ||
| 0.123 | 0.057 | 0.123 | 5 Hydroxytryptamine 2B antagonist | 0.107 0.074 CID_7005 | ||
| 0.072 | 0.006 | 0.072 | Potassium channel small-conductance Ca-activated activator | |||
| 0.071 | 0.005 | 0.071 | Histamine H1 receptor agonist | 0.041 0.037 CID_8663 0.041 0.037 CID_7005 | ||
| 0.079 | 0.013 | 0.079 | Epithelial sodium channel blocker | 0.056 0.034 CID_11318 0.066 0.022 CID_8663 0.059 0.03 CID_7005 | ||
| 0.079 | 0.013 | 0.079 | Lysine-specific demethylase 1A inhibitor | 0.058 0.031 CID_11318 0.072 0.016 CID_8663 0.07 0.018 CID_7005 | ||
| 0.07 | 0.005 | 0.07 | Glutamate (mGluR8) agonist | 0.042 0.019 CID_108063 0.057 0.008 CID_11318 0.057 0.008 CID_8663 0.057 0.008 CID_7005 | ||
| 0.097 | 0.031 | 0.097 | Acetylcholine M4 receptor antagonist | |||
| 0.088 | 0.023 | 0.088 | Orexin receptor 1 antagonist | |||
| 0.091 | 0.026 | 0.105 | Elastase 1 inhibitor | 0.105 0.018 CID_11318 0.075 0.041 CID_8663 | CID_11318 | |
| 0.08 | 0.015 | 0.08 | 5 Hydroxytryptamine 2 agonist | 0.056 0.031 CID_8663 0.059 0.028 CID_7005 | ||
| 0.078 | 0.013 | 0.078 | Oleamide hydrolase inhibitor | 0.064 0.018 CID_8663 0.057 0.022 CID_7005 | ||
| 0.083 | 0.018 | 0.118 | NMDA 2A receptor antagonist | 0.064 0.027 CID_11318 0.118 0.01 CID_8663 0.098 0.014 CID_7005 | CID_8663 | |
| 0.076 | 0.011 | 0.076 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.071 | 0.007 | 0.071 | Sirtuin 2 inhibitor | 0.045 0.015 CID_11318 0.057 0.01 CID_8663 0.06 0.01 CID_7005 | ||
| 0.068 | 0.004 | 0.068 | Vanilloid 3 antagonist | 0.043 0.016 CID_108063 0.054 0.006 CID_11318 0.056 0.005 CID_8663 0.06 0.005 CID_7005 | ||
| 0.099 | 0.035 | 0.099 | Histamine H2 receptor antagonist | |||
| 0.077 | 0.013 | 0.077 | Potassium channel Kv1.3 blocker | 0.06 0.021 CID_11318 0.07 0.015 CID_8663 0.074 0.014 CID_7005 | ||
| 0.083 | 0.019 | 0.149 | Heat shock protein 90 beta antagonist | 0.066 0.032 CID_108063 0.149 0.005 CID_11318 0.124 0.006 CID_8663 0.149 0.005 CID_7005 | CID_7005 | |
| 0.073 | 0.01 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 CID_11318 0.067 0.014 CID_8663 0.053 0.022 CID_7005 | ||
| 0.087 | 0.024 | 0.137 | Aromatase inhibitor | 0.055 0.045 CID_108063 0.136 0.015 CID_11318 0.137 0.015 CID_8663 0.122 0.017 CID_7005 | CID_8663 | |
| 0.076 | 0.014 | 0.076 | Glutamate (mGluR group I) agonist | |||
| 0.25 | 0.187 | 0.25 | Transcription factor inhibitor | 0.237 0.196 CID_11318 0.222 0.207 CID_8663 0.239 0.194 CID_7005 | ||
| 0.079 | 0.017 | 0.079 | Phosphodiesterase 1A inhibitor | 0.058 0.045 CID_8663 0.055 0.054 CID_7005 | ||
| 0.084 | 0.021 | 0.084 | 5 Hydroxytryptamine 5A antagonist | 0.064 0.039 CID_11318 0.068 0.034 CID_8663 0.065 0.037 CID_7005 | ||
| 0.074 | 0.012 | 0.074 | Glutamate (mGluR5) agonist | |||
| 0.073 | 0.011 | 0.073 | Mannosidase inhibitor | 0.048 0.027 CID_108063 0.054 0.022 CID_11318 0.063 0.015 CID_8663 0.06 0.017 CID_7005 | ||
| 0.093 | 0.031 | 0.104 | Lipase inhibitor | 0.101 0.027 CID_11318 0.104 0.025 CID_8663 0.098 0.028 CID_7005 | CID_8663 | |
| 0.09 | 0.029 | 0.09 | Neuronal nicotinic receptor antagonist | 0.081 0.035 CID_108063 0.07 0.045 CID_8663 | ||
| 0.079 | 0.018 | 0.079 | Botulinum neurotoxin type A inhibitor | 0.071 0.024 CID_11318 0.074 0.021 CID_8663 0.078 0.018 CID_7005 | ||
| 0.125 | 0.065 | 0.125 | Histone deacetylase class III inhibitor | 0.102 0.088 CID_8663 | ||
| 0.065 | 0.005 | 0.065 | Heme oxygenase inhibitor | 0.043 0.029 CID_108063 0.048 0.017 CID_11318 0.054 0.009 CID_8663 0.051 0.012 CID_7005 | ||
| 0.084 | 0.024 | 0.084 | Potassium channel (ATP-sensitive) blocker | 0.062 0.057 CID_11318 0.076 0.032 CID_8663 0.063 0.055 CID_7005 | ||
| 0.127 | 0.067 | 0.127 | Glutamate receptor antagonist | 0.113 0.082 CID_8663 | ||
| 0.066 | 0.007 | 0.066 | 5 Hydroxytryptamine 2B agonist | 0.043 0.02 CID_8663 0.039 0.027 CID_7005 | ||
| 0.07 | 0.011 | 0.07 | Glutamate (mGluR1a) antagonist | |||
| 0.084 | 0.025 | 0.348 | CDC25B inhibitor | 0.348 0.004 CID_11318 0.108 0.013 CID_8663 0.191 0.005 CID_7005 | CID_11318 | |
| 0.089 | 0.029 | 0.089 | Phosphodiesterase VI inhibitor | 0.07 0.063 CID_11318 0.086 0.033 CID_8663 0.081 0.04 CID_7005 | ||
| 0.073 | 0.013 | 0.126 | NMDA receptor subunit 3A antagonist | 0.054 0.018 CID_11318 0.126 0.006 CID_8663 0.117 0.007 CID_7005 | CID_8663 | |
| 0.083 | 0.024 | 0.083 | Dopamine uptake inhibitor | 0.054 0.044 CID_108063 0.059 0.039 CID_8663 | ||
| 0.091 | 0.032 | 0.091 | Adenosine A3 receptor antagonist | 0.075 0.05 CID_8663 0.074 0.052 CID_7005 | ||
| 0.085 | 0.026 | 0.085 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.067 | 0.008 | 0.067 | Benzodiazepine antagonist | 0.045 0.039 CID_11318 0.045 0.039 CID_8663 | ||
| 0.069 | 0.01 | 0.078 | Retinoid X receptor agonist | 0.054 0.016 CID_11318 0.057 0.015 CID_8663 0.078 0.008 CID_7005 | CID_7005 | |
| 0.12 | 0.062 | 0.142 | Protein kinase (CK2) alpha inhibitor | 0.142 0.046 CID_11318 0.127 0.057 CID_8663 0.138 0.049 CID_7005 | CID_11318 | |
| 0.083 | 0.025 | 0.083 | Cannabinoid CB1 receptor antagonist | 0.06 0.045 CID_7005 | ||
| 0.073 | 0.015 | 0.073 | Glutamate (mGluR group III) agonist | 0.04 0.034 CID_8663 | ||
| 0.069 | 0.011 | 0.069 | Cholesterol esterase inhibitor | 0.066 0.013 CID_11318 0.057 0.02 CID_8663 0.067 0.012 CID_7005 | ||
| 0.061 | 0.004 | 0.072 | Alpha 2a adrenoreceptor agonist | 0.072 0.003 CID_108063 0.053 0.004 CID_11318 0.037 0.004 CID_8663 0.044 0.004 CID_7005 | CID_108063 | |
| 0.061 | 0.003 | 0.061 | Imidazoline I1 receptor antagonist | 0.031 0.007 CID_108063 0.023 0.011 CID_11318 0.027 0.009 CID_8663 0.028 0.008 CID_7005 | ||
| 0.062 | 0.005 | 0.062 | Melatonin receptor 1A agonist | 0.032 0.025 CID_11318 0.045 0.01 CID_8663 0.036 0.018 CID_7005 | ||
| 0.08 | 0.023 | 0.117 | Beta 3 adrenoreceptor antagonist | 0.11 0.012 CID_11318 0.117 0.01 CID_8663 0.101 0.014 CID_7005 | CID_8663 | |
| 0.081 | 0.024 | 0.163 | Xanthine dehydrogenase inhibitor | 0.163 0.006 CID_11318 0.14 0.008 CID_8663 0.145 0.008 CID_7005 | CID_11318 | |
| 0.088 | 0.032 | 0.088 | Calcium channel L-type blocker | |||
| 0.064 | 0.008 | 0.064 | Potassium channel Kv1.1 blocker | 0.037 0.029 CID_8663 0.035 0.034 CID_7005 | ||
| 0.077 | 0.021 | 0.077 | Histone deacetylase SIRT3 inhibitor | 0.066 0.035 CID_8663 0.06 0.048 CID_7005 | ||
| 0.076 | 0.02 | 0.076 | Nicotinic alpha7 receptor agonist | |||
| 0.077 | 0.022 | 0.077 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.041 CID_11318 0.061 0.035 CID_8663 0.059 0.039 CID_7005 | ||
| 0.061 | 0.005 | 0.061 | Free fatty acid receptor 1 antagonist | 0.046 0.011 CID_11318 0.048 0.01 CID_8663 0.053 0.008 CID_7005 | ||
| 0.068 | 0.013 | 0.068 | Heparanase inhibitor | 0.062 0.02 CID_108063 0.058 0.026 CID_11318 0.064 0.018 CID_8663 0.064 0.017 CID_7005 | ||
| 0.102 | 0.047 | 0.118 | Alpha 2 adrenoreceptor antagonist | 0.085 0.06 CID_108063 0.118 0.037 CID_11318 0.091 0.055 CID_8663 0.081 0.064 CID_7005 | CID_11318 | |
| 0.091 | 0.036 | 0.091 | Histone deacetylase SIRT2 inhibitor | |||
| 0.064 | 0.01 | 0.082 | Nicotinic acid receptor agonist | 0.045 0.017 CID_11318 0.082 0.006 CID_8663 0.056 0.012 CID_7005 | CID_8663 | |
| 0.1 | 0.045 | 0.1 | Pim-3 kinase inhibitor | 0.08 0.076 CID_8663 | ||
| 0.061 | 0.007 | 0.061 | Delayed rectifier potassium channel blocker | 0.045 0.016 CID_11318 0.056 0.009 CID_8663 0.051 0.011 CID_7005 | ||
| 0.095 | 0.041 | 0.15 | Adrenaline agonist | 0.139 0.018 CID_11318 0.15 0.015 CID_8663 0.121 0.025 CID_7005 | CID_8663 | |
| 0.076 | 0.022 | 0.091 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.084 0.017 CID_11318 0.091 0.014 CID_8663 0.087 0.015 CID_7005 | CID_8663 | |
| 0.085 | 0.032 | 0.085 | CDC7 inhibitor | |||
| 0.069 | 0.016 | 0.069 | Prolyl endopeptidase inhibitor | 0.052 0.034 CID_108063 0.054 0.031 CID_11318 0.052 0.034 CID_8663 0.049 0.038 CID_7005 | ||
| 0.244 | 0.191 | 0.43 | Alpha-glucosidase inhibitor | 0.43 0.103 CID_11318 0.375 0.125 CID_8663 0.358 0.132 CID_7005 | CID_11318 | |
| 0.066 | 0.012 | 0.066 | CC chemokine 4 receptor antagonist | |||
| 0.093 | 0.04 | 0.132 | Alpha 2a adrenoreceptor antagonist | 0.088 0.043 CID_108063 0.132 0.026 CID_11318 0.092 0.04 CID_8663 0.083 0.046 CID_7005 | CID_11318 | |
| 0.087 | 0.034 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.085 0.037 CID_8663 0.072 0.065 CID_7005 | ||
| 0.077 | 0.024 | 0.077 | Phosphodiesterase 1B inhibitor | 0.066 0.035 CID_8663 0.058 0.045 CID_7005 | ||
| 0.073 | 0.02 | 0.076 | Nicotinic receptor alpha7 subunit antagonist | 0.076 0.019 CID_108063 0.05 0.044 CID_8663 | CID_108063 | |
| 0.063 | 0.011 | 0.063 | Kainate receptor 2 antagonist | 0.04 0.022 CID_7005 | ||
| 0.123 | 0.071 | 0.123 | Cholinergic antagonist | 0.104 0.09 CID_108063 0.11 0.084 CID_8663 | ||
| 0.072 | 0.019 | 0.104 | Carbonic anhydrase XIV inhibitor | 0.069 0.02 CID_11318 0.104 0.01 CID_8663 0.065 0.022 CID_7005 | CID_8663 | |
| 0.077 | 0.025 | 0.077 | Glutamate (mGluR1) antagonist | |||
| 0.087 | 0.035 | 0.094 | Prostaglandin-E synthase inhibitor | 0.084 0.036 CID_11318 0.076 0.042 CID_8663 0.094 0.03 CID_7005 | CID_7005 | |
| 0.064 | 0.012 | 0.064 | AICAR transformylase inhibitor | 0.05 0.022 CID_11318 0.057 0.016 CID_8663 0.056 0.017 CID_7005 | ||
| 0.061 | 0.01 | 0.061 | AMPA 4 receptor antagonist | 0.038 0.031 CID_11318 0.049 0.016 CID_8663 0.043 0.022 CID_7005 | ||
| 0.057 | 0.006 | 0.057 | Uridine phosphorylase inhibitor | 0.029 0.018 CID_108063 0.04 0.012 CID_11318 0.047 0.009 CID_8663 0.047 0.009 CID_7005 | ||
| 0.059 | 0.007 | 0.059 | Angiotensin AT1 receptor antagonist | 0.04 0.032 CID_11318 0.044 0.026 CID_8663 0.044 0.026 CID_7005 | ||
| 0.079 | 0.028 | 0.079 | Orexin receptor antagonist | |||
| 0.103 | 0.052 | 0.162 | Breast cancer-resistant protein inhibitor | 0.104 0.052 CID_11318 0.162 0.02 CID_8663 0.148 0.024 CID_7005 | CID_8663 | |
| 0.065 | 0.014 | 0.065 | Thymidylate synthase inhibitor | 0.057 0.019 CID_11318 0.054 0.023 CID_8663 0.055 0.021 CID_7005 | ||
| 0.071 | 0.02 | 0.071 | AMPA receptor antagonist | 0.052 0.029 CID_8663 0.053 0.029 CID_7005 | ||
| 0.075 | 0.024 | 0.075 | Nicotinic neuronal receptor agonist | |||
| 0.077 | 0.026 | 0.077 | Acetylcholine M5 receptor antagonist | 0.062 0.039 CID_8663 0.056 0.049 CID_7005 | ||
| 0.086 | 0.036 | 0.086 | Protein kinase B beta inhibitor | |||
| 0.086 | 0.036 | 0.086 | Cannabinoid receptor antagonist | 0.061 0.06 CID_7005 | ||
| 0.128 | 0.078 | 0.146 | CC chemokine 6 receptor antagonist | 0.138 0.045 CID_11318 0.134 0.057 CID_8663 0.146 0.028 CID_7005 | CID_7005 | |
| 0.054 | 0.004 | 0.054 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.012 CID_11318 0.042 0.013 CID_8663 0.04 0.016 CID_7005 | ||
| 0.054 | 0.005 | 0.054 | Nicotinic alpha3beta4 receptor agonist | 0.029 0.023 CID_11318 0.039 0.011 CID_8663 0.033 0.017 CID_7005 | ||
| 0.071 | 0.021 | 0.088 | Dihydroorotate dehydrogenase inhibitor | 0.088 0.015 CID_11318 0.082 0.017 CID_8663 0.084 0.016 CID_7005 | CID_11318 | |
| 0.107 | 0.058 | 0.127 | Protein kinase (CK2) inhibitor | 0.127 0.044 CID_11318 0.113 0.053 CID_8663 0.123 0.046 CID_7005 | CID_11318 | |
| 0.109 | 0.06 | 0.159 | Mediator release inhibitor | 0.159 0.025 CID_11318 0.124 0.044 CID_8663 0.122 0.046 CID_7005 | CID_11318 | |
| 0.061 | 0.012 | 0.086 | Liver X receptor alpha agonist | 0.063 0.011 CID_11318 0.086 0.006 CID_8663 0.073 0.008 CID_7005 | CID_8663 | |
| 0.057 | 0.007 | 0.057 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.012 CID_11318 0.037 0.014 CID_8663 0.05 0.009 CID_7005 | ||
| 0.072 | 0.023 | 0.088 | Heme oxygenase stimulant | 0.069 0.026 CID_11318 0.085 0.012 CID_8663 0.088 0.011 CID_7005 | CID_7005 | |
| 0.077 | 0.029 | 0.077 | Adrenaline uptake inhibitor | |||
| 0.119 | 0.071 | 0.119 | Acetylcholine antagonist | 0.1 0.093 CID_108063 0.106 0.084 CID_8663 | ||
| 0.073 | 0.025 | 0.073 | Acetylcholine muscarinic agonist | |||
| 0.065 | 0.017 | 0.065 | Adenosine deaminase inhibitor | 0.05 0.03 CID_11318 0.06 0.021 CID_8663 0.059 0.022 CID_7005 | ||
| 0.067 | 0.02 | 0.067 | 5 Hydroxytryptamine 1B agonist | |||
| 0.107 | 0.06 | 0.107 | MAP kinase kinase kinase inhibitor | |||
| 0.058 | 0.01 | 0.058 | Vascular adhesion protein 1 inhibitor | |||
| 0.066 | 0.019 | 0.068 | Leukotriene C antagonist | 0.053 0.052 CID_108063 0.063 0.022 CID_11318 0.068 0.016 CID_8663 0.066 0.019 CID_7005 | CID_8663 | |
| 0.074 | 0.027 | 0.074 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.097 | 0.05 | 0.097 | Polo-like kinase-1 inhibitor | |||
| 0.149 | 0.102 | 0.149 | TRKC antagonist | |||
| 0.064 | 0.018 | 0.199 | Estradiol 17 beta-dehydrogenase inhibitor | 0.167 0.005 CID_11318 0.199 0.004 CID_8663 0.188 0.005 CID_7005 | CID_8663 | |
| 0.074 | 0.027 | 0.074 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.055 | 0.009 | 0.055 | Integrin alpha2 antagonist | 0.038 0.023 CID_8663 0.037 0.026 CID_7005 | ||
| 0.067 | 0.021 | 0.067 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.061 | 0.015 | 0.061 | Histone deacetylase 7 inhibitor | |||
| 0.057 | 0.011 | 0.057 | Acid-sensing ion channel blocker | 0.037 0.034 CID_11318 0.04 0.029 CID_8663 0.044 0.023 CID_7005 | ||
| 0.073 | 0.028 | 0.083 | I kappa B kinase 2 inhibitor | 0.057 0.054 CID_11318 0.067 0.037 CID_8663 0.083 0.02 CID_7005 | CID_7005 | |
| 0.101 | 0.056 | 0.157 | Protein kinase C mu inhibitor | 0.157 0.023 CID_11318 | CID_11318 | |
| 0.076 | 0.031 | 0.076 | Cannabinoid CB1 receptor agonist | |||
| 0.056 | 0.011 | 0.056 | Sphingosine kinase 1 inhibitor | 0.052 0.014 CID_11318 0.052 0.014 CID_8663 0.055 0.012 CID_7005 | ||
| 0.049 | 0.004 | 0.049 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 CID_7005 | ||
| 0.059 | 0.014 | 0.059 | Thymidine kinase inhibitor | 0.04 0.029 CID_11318 0.045 0.023 CID_8663 0.048 0.021 CID_7005 | ||
| 0.052 | 0.007 | 0.058 | CF transmembrane conductance regulator antagonist | 0.052 0.007 CID_11318 0.058 0.005 CID_8663 0.055 0.005 CID_7005 | CID_8663 | |
| 0.052 | 0.008 | 0.068 | Liver X receptor beta antagonist | 0.045 0.01 CID_11318 0.068 0.005 CID_8663 0.059 0.006 CID_7005 | CID_8663 | |
| 0.053 | 0.008 | 0.053 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 CID_108063 0.026 0.021 CID_11318 0.031 0.017 CID_8663 0.031 0.017 CID_7005 | ||
| 0.057 | 0.013 | 0.057 | Dihydropteroate synthase inhibitor | 0.041 0.025 CID_11318 0.057 0.013 CID_8663 0.047 0.019 CID_7005 | ||
| 0.053 | 0.01 | 0.056 | Retinoid X receptor antagonist | 0.048 0.015 CID_11318 0.048 0.014 CID_8663 0.056 0.009 CID_7005 | CID_7005 | |
| 0.058 | 0.015 | 0.065 | Urate transporter 1 inhibitor | 0.049 0.019 CID_11318 0.065 0.012 CID_8663 0.061 0.013 CID_7005 | CID_8663 | |
| 0.091 | 0.047 | 0.1 | I kappa B kinase inhibitor | 0.078 0.063 CID_8663 0.1 0.038 CID_7005 | CID_7005 | |
| 0.05 | 0.007 | 0.05 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 CID_11318 0.046 0.01 CID_8663 0.046 0.01 CID_7005 | ||
| 0.047 | 0.004 | 0.047 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 CID_11318 0.039 0.005 CID_8663 0.033 0.009 CID_7005 | ||
| 0.067 | 0.024 | 0.08 | Beta 2 adrenoreceptor agonist | 0.059 0.056 CID_108063 0.078 0.011 CID_11318 0.08 0.009 CID_8663 0.075 0.013 CID_7005 | CID_8663 | |
| 0.136 | 0.094 | 0.351 | Protein-tyrosine phosphatase inhibitor | 0.351 0.012 CID_11318 0.24 0.034 CID_8663 0.289 0.021 CID_7005 | CID_11318 | |
| 0.087 | 0.044 | 0.087 | Transforming growth factor beta 3 antagonist | |||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | 0.043 0.031 CID_8663 0.041 0.038 CID_7005 | ||
| 0.125 | 0.082 | 0.125 | Calcium channel blocker | |||
| 0.056 | 0.013 | 0.056 | TRPM8 blocker | 0.034 0.032 CID_8663 0.044 0.02 CID_7005 | ||
| 0.078 | 0.036 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.052 CID_11318 0.079 0.035 CID_8663 0.078 0.037 CID_7005 | CID_8663 | |
| 0.045 | 0.003 | 0.045 | Complement factor 1s inhibitor | 0.025 0.019 CID_108063 0.029 0.009 CID_11318 0.034 0.005 CID_8663 0.034 0.005 CID_7005 | ||
| 0.063 | 0.021 | 0.063 | Acetylcholine M1 receptor agonist | |||
| 0.049 | 0.007 | 0.049 | Angiotensin II receptor antagonist | 0.034 0.024 CID_8663 0.033 0.025 CID_7005 | ||
| 0.052 | 0.011 | 0.052 | MAP3K5 inhibitor | 0.04 0.026 CID_8663 | ||
| 0.064 | 0.023 | 0.064 | Dopamine transporter inhibitor | |||
| 0.045 | 0.005 | 0.045 | Purinergic P2Y15 antagonist | 0.032 0.014 CID_108063 0.034 0.011 CID_11318 0.037 0.009 CID_8663 0.037 0.009 CID_7005 | ||
| 0.054 | 0.013 | 0.054 | Phosphoglycerate kinase inhibitor | 0.043 0.017 CID_11318 0.049 0.014 CID_8663 0.046 0.016 CID_7005 | ||
| 0.044 | 0.004 | 0.044 | Hedgehog signaling activator | 0.029 0.015 CID_108063 0.041 0.004 CID_11318 0.039 0.005 CID_8663 0.044 0.004 CID_7005 | ||
| 0.088 | 0.047 | 0.33 | Topoisomerase II alpha inhibitor | 0.33 0.006 CID_11318 0.263 0.009 CID_8663 0.317 0.006 CID_7005 | CID_11318 | |
| 0.048 | 0.007 | 0.048 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.02 CID_8663 0.028 0.015 CID_7005 | ||
| 0.054 | 0.014 | 0.054 | Glutamate (mGluR group II) antagonist | 0.041 0.023 CID_8663 | ||
| 0.113 | 0.073 | 0.446 | Topoisomerase II inhibitor | 0.446 0.008 CID_11318 0.324 0.015 CID_8663 0.397 0.01 CID_7005 | CID_11318 | |
| 0.059 | 0.019 | 0.059 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 CID_8663 | ||
| 0.048 | 0.008 | 0.052 | Protein kinase (CK2) beta inhibitor | 0.052 0.006 CID_11318 0.05 0.007 CID_8663 0.049 0.008 CID_7005 | CID_11318 | |
| 0.044 | 0.005 | 0.044 | Glutamate (mGluR1) agonist | 0.029 0.01 CID_8663 0.025 0.016 CID_7005 | ||
| 0.082 | 0.043 | 0.265 | Telomerase inhibitor | 0.265 0.008 CID_11318 0.194 0.014 CID_7005 | CID_11318 | |
| 0.067 | 0.028 | 0.089 | Beta 1 adrenoreceptor antagonist | 0.089 0.013 CID_11318 0.081 0.017 CID_8663 0.076 0.02 CID_7005 | CID_11318 | |
| 0.063 | 0.024 | 0.063 | Sphingosine 1-phosphate receptor 1 antagonist | 0.061 0.027 CID_8663 0.053 0.045 CID_7005 | ||
| 0.065 | 0.026 | 0.067 | Cannabinoid CB2 receptor antagonist | 0.046 0.04 CID_8663 0.067 0.025 CID_7005 | CID_7005 | |
| 0.053 | 0.014 | 0.237 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.148 0.004 CID_11318 0.237 0.003 CID_8663 0.204 0.004 CID_7005 | CID_8663 | |
| 0.046 | 0.008 | 0.046 | Methionyl aminopeptidase 1 inhibitor | 0.029 0.027 CID_7005 | ||
| 0.044 | 0.006 | 0.044 | Nicotinic alpha4beta2 receptor agonist | 0.031 0.017 CID_8663 | ||
| 0.07 | 0.032 | 0.07 | Carbonic anhydrase IX inhibitor | 0.063 0.036 CID_8663 | ||
| 0.063 | 0.025 | 0.063 | Histamine agonist | |||
| 0.047 | 0.009 | 0.083 | ATP citrate lysase inhibitor | 0.055 0.006 CID_108063 0.063 0.005 CID_11318 0.07 0.004 CID_8663 0.083 0.004 CID_7005 | CID_7005 | |
| 0.073 | 0.034 | 0.108 | Beta adrenoreceptor antagonist | 0.108 0.014 CID_11318 0.099 0.017 CID_8663 0.091 0.02 CID_7005 | CID_11318 | |
| 0.119 | 0.081 | 0.482 | Tubulin antagonist | 0.482 0.008 CID_108063 0.397 0.012 CID_11318 0.247 0.026 CID_8663 0.286 0.021 CID_7005 | CID_108063 | |
| 0.095 | 0.057 | 0.104 | ABCA1 expression enhancer | 0.103 0.046 CID_8663 0.104 0.045 CID_7005 | CID_7005 | |
| 0.058 | 0.02 | 0.058 | Carbonic anhydrase IV inhibitor | 0.044 0.029 CID_8663 0.039 0.034 CID_7005 | ||
| 0.056 | 0.018 | 0.056 | Kainate receptor antagonist | 0.038 0.03 CID_8663 0.041 0.028 CID_7005 | ||
| 0.067 | 0.03 | 0.067 | Alpha 1 adrenoreceptor agonist | 0.055 0.043 CID_11318 0.058 0.039 CID_8663 | ||
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | 0.038 0.03 CID_7005 | ||
| 0.042 | 0.005 | 0.052 | Estrogen-related receptor gamma antagonist | 0.042 0.005 CID_11318 0.052 0.003 CID_8663 0.045 0.004 CID_7005 | CID_8663 | |
| 0.046 | 0.009 | 0.046 | Retinoid X alpha receptor antagonist | 0.04 0.015 CID_11318 0.039 0.016 CID_8663 0.042 0.013 CID_7005 | ||
| 0.056 | 0.019 | 0.061 | Oxytocin agonist | 0.05 0.024 CID_11318 0.061 0.016 CID_8663 0.055 0.021 CID_7005 | CID_8663 | |
| 0.042 | 0.005 | 0.042 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 CID_108063 0.024 0.019 CID_11318 0.026 0.015 CID_8663 0.026 0.015 CID_7005 | ||
| 0.048 | 0.011 | 0.06 | Liver X receptor beta agonist | 0.034 0.022 CID_11318 0.06 0.008 CID_8663 0.043 0.013 CID_7005 | CID_8663 | |
| 0.041 | 0.004 | 0.041 | Acid ceramidase inhibitor | 0.025 0.021 CID_8663 | ||
| 0.064 | 0.028 | 0.064 | Toll-Like receptor 8 antagonist | |||
| 0.051 | 0.015 | 0.051 | Histone deacetylase 9 inhibitor | 0.038 0.03 CID_8663 | ||
| 0.158 | 0.122 | 0.158 | MAP kinase kinase 5 inhibitor | |||
| 0.072 | 0.036 | 0.072 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.074 | 0.038 | 0.074 | Carbonic anhydrase inhibitor | 0.071 0.039 CID_8663 | ||
| 0.041 | 0.005 | 0.041 | Integrin alpha2beta1 antagonist | 0.028 0.016 CID_8663 0.026 0.018 CID_7005 | ||
| 0.123 | 0.088 | 0.123 | Histone deacetylase SIRT1 inhibitor | 0.123 0.087 CID_8663 0.11 0.104 CID_7005 | ||
| 0.064 | 0.029 | 0.064 | GABA receptor antagonist | 0.053 0.039 CID_8663 0.051 0.042 CID_7005 | ||
| 0.061 | 0.026 | 0.061 | Thromboxane synthase inhibitor | 0.055 0.036 CID_8663 0.058 0.031 CID_7005 | ||
| 0.052 | 0.017 | 0.054 | Progesterone antagonist | 0.034 0.026 CID_11318 0.054 0.017 CID_8663 0.048 0.019 CID_7005 | CID_8663 | |
| 0.084 | 0.05 | 0.084 | Phosphodiesterase 3A inhibitor | 0.077 0.06 CID_8663 | ||
| 0.072 | 0.038 | 0.072 | Neutrophil collagenase inhibitor | 0.07 0.04 CID_11318 0.063 0.046 CID_8663 0.062 0.048 CID_7005 | ||
| 0.057 | 0.022 | 0.057 | Histamine H4 receptor antagonist | |||
| 0.038 | 0.004 | 0.04 | Vanilloid 2 agonist | 0.024 0.02 CID_108063 0.032 0.008 CID_11318 0.034 0.006 CID_8663 0.04 0.004 CID_7005 | CID_7005 | |
| 0.046 | 0.013 | 0.087 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.069 0.006 CID_11318 0.087 0.005 CID_8663 0.068 0.006 CID_7005 | CID_8663 | |
| 0.049 | 0.015 | 0.049 | Farnesoid X receptor agonist | 0.041 0.022 CID_8663 0.037 0.028 CID_7005 | ||
| 0.049 | 0.015 | 0.049 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.049 | 0.016 | 0.049 | Arginase inhibitor | 0.039 0.023 CID_11318 0.049 0.016 CID_8663 0.045 0.019 CID_7005 | ||
| 0.042 | 0.009 | 0.042 | Kynurenine 3 monooxygenase inhibitor | 0.025 0.02 CID_8663 | ||
| 0.074 | 0.04 | 0.241 | Potassium channel large-conductance Ca-activated activator | 0.111 0.019 CID_11318 0.133 0.014 CID_8663 0.241 0.005 CID_7005 | CID_7005 | |
| 0.04 | 0.007 | 0.04 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 CID_8663 | ||
| 0.062 | 0.029 | 0.062 | GABA A receptor antagonist | 0.05 0.041 CID_8663 0.048 0.044 CID_7005 | ||
| 0.046 | 0.013 | 0.046 | Acetylcholine M4 receptor agonist | |||
| 0.042 | 0.009 | 0.042 | Epoxide hydrolase 1 inhibitor | |||
| 0.041 | 0.009 | 0.044 | Glutamate (mGluR3) agonist | 0.038 0.012 CID_11318 0.044 0.007 CID_8663 0.041 0.009 CID_7005 | CID_8663 | |
| 0.042 | 0.009 | 0.122 | Estrogen-related receptor beta antagonist | 0.052 0.005 CID_11318 0.122 0.002 CID_8663 0.069 0.004 CID_7005 | CID_8663 | |
| 0.056 | 0.024 | 0.056 | HCV NS3/NS4A protease inhibitor | |||
| 0.071 | 0.039 | 0.071 | Histone deacetylase inhibitor | |||
| 0.037 | 0.005 | 0.037 | Glucosylceramidase stimulant | |||
| 0.071 | 0.039 | 0.159 | Dopamine D1 antagonist | 0.159 0.014 CID_11318 0.132 0.018 CID_8663 0.121 0.02 CID_7005 | CID_11318 | |
| 0.097 | 0.066 | 0.097 | Cyclin-dependent kinase 9 inhibitor | 0.094 0.07 CID_7005 | ||
| 0.066 | 0.035 | 0.066 | Collagenase 3 inhibitor | |||
| 0.073 | 0.041 | 0.073 | Protein kinase C alpha inhibitor | |||
| 0.038 | 0.007 | 0.038 | Myristoyl transferase inhibitor | |||
| 0.058 | 0.026 | 0.083 | Beta 2 adrenoreceptor antagonist | 0.083 0.01 CID_11318 0.078 0.013 CID_8663 0.07 0.016 CID_7005 | CID_11318 | |
| 0.038 | 0.007 | 0.038 | Thymidine phosphorylase inhibitor | 0.03 0.012 CID_11318 0.028 0.014 CID_8663 0.029 0.013 CID_7005 | ||
| 0.051 | 0.02 | 0.051 | CDK5/p25 inhibitor | 0.046 0.024 CID_8663 0.047 0.023 CID_7005 | ||
| 0.076 | 0.045 | 0.076 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.042 | 0.012 | 0.042 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.076 | 0.047 | 0.076 | Metalloproteinase-9 inhibitor | 0.075 0.048 CID_11318 0.076 0.048 CID_8663 0.07 0.055 CID_7005 | ||
| 0.086 | 0.056 | 0.086 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.063 | 0.034 | 0.063 | Potassium channel Kv1.5 blocker | |||
| 0.063 | 0.033 | 0.063 | Cyclin A1 inhibitor | |||
| 0.038 | 0.008 | 0.038 | MAP3K8 inhibitor | |||
| 0.095 | 0.066 | 0.095 | Butyrylcholinesterase inhibitor | 0.082 0.08 CID_11318 0.085 0.076 CID_8663 0.09 0.07 CID_7005 | ||
| 0.033 | 0.004 | 0.037 | Alpha 2c adrenoreceptor agonist | 0.037 0.004 CID_108063 0.02 0.011 CID_11318 0.018 0.013 CID_8663 0.019 0.012 CID_7005 | CID_108063 | |
| 0.048 | 0.019 | 0.048 | Plasmepsin II inhibitor | 0.042 0.026 CID_8663 0.038 0.035 CID_7005 | ||
| 0.06 | 0.031 | 0.06 | MAP kinase kinase 9 inhibitor | |||
| 0.052 | 0.023 | 0.052 | Sphingosine 1-phosphate receptor agonist | 0.044 0.032 CID_8663 | ||
| 0.04 | 0.011 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.034 0.014 CID_8663 0.026 0.021 CID_7005 | ||
| 0.041 | 0.012 | 0.041 | Cholesterol ester transfer protein antagonist | 0.041 0.012 CID_11318 0.032 0.021 CID_8663 0.038 0.015 CID_7005 | ||
| 0.035 | 0.007 | 0.035 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 CID_108063 0.026 0.019 CID_11318 0.029 0.012 CID_8663 0.028 0.014 CID_7005 | ||
| 0.033 | 0.004 | 0.047 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 CID_11318 0.047 0.003 CID_8663 0.034 0.004 CID_7005 | CID_8663 | |
| 0.033 | 0.004 | 0.033 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 CID_11318 0.021 0.009 CID_8663 0.027 0.005 CID_7005 | ||
| 0.04 | 0.012 | 0.04 | Adenosine uptake inhibitor | |||
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR4) agonist | 0.031 0.029 CID_8663 | ||
| 0.08 | 0.052 | 0.08 | Metalloproteinase-2 inhibitor | 0.076 0.057 CID_11318 0.079 0.054 CID_8663 0.076 0.056 CID_7005 | ||
| 0.062 | 0.034 | 0.062 | Carbonic anhydrase I inhibitor | 0.053 0.041 CID_8663 | ||
| 0.037 | 0.009 | 0.141 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.093 0.004 CID_11318 0.141 0.003 CID_8663 0.132 0.003 CID_7005 | CID_8663 | |
| 0.031 | 0.003 | 0.031 | Imidazoline I2 receptor antagonist | 0.014 0.005 CID_108063 0.011 0.008 CID_11318 0.012 0.006 CID_8663 0.013 0.005 CID_7005 | ||
| 0.05 | 0.022 | 0.051 | Histone deacetylase 8 inhibitor | 0.051 0.021 CID_11318 0.039 0.031 CID_8663 | CID_11318 | |
| 0.075 | 0.047 | 0.075 | Epoxide hydrolase inhibitor | |||
| 0.062 | 0.034 | 0.062 | Carbonic anhydrase II inhibitor | 0.056 0.038 CID_8663 | ||
| 0.041 | 0.014 | 0.041 | Dipeptidyl peptidase II inhibitor | |||
| 0.045 | 0.018 | 0.045 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.055 | 0.028 | 0.055 | Phosphorylase inhibitor | 0.053 0.029 CID_8663 0.042 0.035 CID_7005 | ||
| 0.039 | 0.012 | 0.039 | Purinergic P2Y14 antagonist | |||
| 0.06 | 0.033 | 0.063 | Carbonic anhydrase XII inhibitor | 0.063 0.032 CID_8663 | CID_8663 | |
| 0.064 | 0.037 | 0.069 | Acetylcholine M3 receptor antagonist | 0.069 0.032 CID_8663 0.058 0.044 CID_7005 | CID_8663 | |
| 0.105 | 0.078 | 0.105 | Calcium channel (voltage-sensitive) blocker | |||
| 0.034 | 0.007 | 0.034 | Complement factor 1r inhibitor | |||
| 0.036 | 0.009 | 0.036 | Calcium-sensing receptor agonist | 0.026 0.02 CID_7005 | ||
| 0.036 | 0.009 | 0.052 | Sodium/glucose cotransporter 2 inhibitor | 0.051 0.006 CID_108063 0.033 0.011 CID_11318 0.046 0.007 CID_8663 0.052 0.006 CID_7005 | CID_7005 | |
| 0.052 | 0.025 | 0.071 | Carbonic anhydrase VII inhibitor | 0.052 0.026 CID_11318 0.071 0.015 CID_8663 0.054 0.024 CID_7005 | CID_8663 | |
| 0.039 | 0.012 | 0.039 | Glutamate (mGluR2) antagonist | 0.028 0.023 CID_8663 | ||
| 0.031 | 0.004 | 0.031 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 CID_11318 0.025 0.007 CID_8663 0.025 0.007 CID_7005 | ||
| 0.048 | 0.022 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.029 CID_8663 | ||
| 0.045 | 0.018 | 0.055 | Inosine monophosphate dehydrogenase inhibitor | 0.036 0.025 CID_8663 0.055 0.012 CID_7005 | CID_7005 | |
| 0.033 | 0.006 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.009 CID_8663 0.026 0.012 CID_7005 | ||
| 0.055 | 0.028 | 0.055 | Bombesin 2 receptor antagonist | 0.049 0.035 CID_8663 0.047 0.037 CID_7005 | ||
| 0.044 | 0.018 | 0.044 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.04 | 0.014 | 0.04 | AMPA 3 receptor antagonist | 0.027 0.022 CID_8663 | ||
| 0.054 | 0.028 | 0.096 | Plasminogen activator inhibitor antagonist | 0.093 0.012 CID_11318 0.096 0.011 CID_8663 0.09 0.012 CID_7005 | CID_8663 | |
| 0.043 | 0.018 | 0.044 | Leukotriene C4 antagonist | 0.039 0.026 CID_11318 0.044 0.016 CID_8663 0.042 0.02 CID_7005 | CID_8663 | |
| 0.044 | 0.019 | 0.054 | Kinesin antagonist | 0.054 0.015 CID_8663 | CID_8663 | |
| 0.044 | 0.019 | 0.054 | Kinesin-like protein 1 inhibitor | 0.054 0.015 CID_8663 | CID_8663 | |
| 0.057 | 0.032 | 0.09 | Leukotriene B4 antagonist | 0.071 0.019 CID_11318 0.073 0.018 CID_8663 0.09 0.012 CID_7005 | CID_7005 | |
| 0.084 | 0.059 | 0.084 | Bcr-Abl kinase inhibitor | 0.074 0.072 CID_8663 | ||
| 0.03 | 0.004 | 0.038 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_108063 0.018 0.008 CID_11318 0.038 0.004 CID_8663 0.027 0.005 CID_7005 | CID_8663 | |
| 0.067 | 0.042 | 0.1 | Leukotriene antagonist | 0.077 0.034 CID_11318 0.087 0.028 CID_8663 0.1 0.022 CID_7005 | CID_7005 | |
| 0.051 | 0.026 | 0.051 | Purinergic P2Y antagonist | 0.043 0.033 CID_8663 0.048 0.028 CID_7005 | ||
| 0.043 | 0.018 | 0.043 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.055 | 0.03 | 0.055 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.028 | 0.005 | 0.028 | Carbonic anhydrase X inhibitor | |||
| 0.028 | 0.005 | 0.028 | Carbonic anhydrase VIII inhibitor | |||
| 0.027 | 0.003 | 0.027 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 CID_11318 0.019 0.004 CID_8663 0.019 0.004 CID_7005 | ||
| 0.083 | 0.059 | 0.083 | Phosphodiesterase IV inhibitor | 0.081 0.06 CID_8663 | ||
| 0.048 | 0.025 | 0.048 | Leukocyte elastase inhibitor | |||
| 0.07 | 0.047 | 0.07 | I kappa B kinase 1 inhibitor | |||
| 0.155 | 0.131 | 0.155 | Growth factor agonist | 0.149 0.144 CID_8663 | ||
| 0.029 | 0.006 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_108063 0.025 0.011 CID_11318 0.026 0.009 CID_8663 0.026 0.01 CID_7005 | ||
| 0.028 | 0.005 | 0.028 | Retinoid X beta receptor antagonist | 0.022 0.011 CID_11318 0.022 0.01 CID_8663 0.024 0.008 CID_7005 | ||
| 0.038 | 0.016 | 0.038 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.074 | 0.051 | 0.351 | CDC25A inhibitor | 0.351 0.003 CID_11318 0.1 0.028 CID_8663 0.19 0.008 CID_7005 | CID_11318 | |
| 0.037 | 0.015 | 0.037 | 5 Hydroxytryptamine 1D agonist | |||
| 0.027 | 0.004 | 0.037 | Antibiotic Anthracycline-like | 0.019 0.013 CID_108063 0.03 0.004 CID_11318 0.029 0.004 CID_8663 0.037 0.003 CID_7005 | CID_7005 | |
| 0.042 | 0.019 | 0.042 | Orexin receptor 2 antagonist | |||
| 0.026 | 0.004 | 0.026 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_108063 0.013 0.01 CID_8663 0.013 0.01 CID_7005 | ||
| 0.082 | 0.06 | 0.115 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.115 0.028 CID_8663 0.08 0.063 CID_7005 | CID_8663 | |
| 0.065 | 0.043 | 0.065 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.032 | 0.01 | 0.04 | Sodium/glucose cotransporter inhibitor | 0.04 0.007 CID_108063 0.028 0.013 CID_11318 0.039 0.007 CID_8663 0.04 0.007 CID_7005 | CID_7005 | |
| 0.027 | 0.006 | 0.027 | Cyclin T1 inhibitor | |||
| 0.039 | 0.017 | 0.044 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.014 CID_8663 0.044 0.013 CID_7005 | CID_7005 | |
| 0.089 | 0.067 | 0.201 | Uric acid excretion stimulant | 0.201 0.013 CID_11318 0.171 0.018 CID_8663 0.165 0.019 CID_7005 | CID_11318 | |
| 0.055 | 0.033 | 0.055 | Dipeptidyl peptidase inhibitor | |||
| 0.038 | 0.017 | 0.038 | Calcium release-activated channel blocker | |||
| 0.057 | 0.036 | 0.06 | Bombesin 3 receptor antagonist | 0.06 0.033 CID_7005 | CID_7005 | |
| 0.074 | 0.053 | 0.074 | Rho-associated kinase I inhibitor | |||
| 0.096 | 0.075 | 0.096 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.029 | 0.008 | 0.029 | ICAM 1 antagonist | 0.024 0.014 CID_8663 | ||
| 0.03 | 0.009 | 0.035 | Prostaglandin F2 alpha agonist | 0.024 0.014 CID_108063 0.026 0.012 CID_11318 0.032 0.008 CID_8663 0.035 0.007 CID_7005 | CID_7005 | |
| 0.025 | 0.005 | 0.025 | Complement factor D inhibitor | 0.018 0.013 CID_8663 | ||
| 0.042 | 0.021 | 0.042 | Potassium channel KCNQ activator | |||
| 0.042 | 0.021 | 0.042 | Delayed rectifier potassium channel activator | |||
| 0.051 | 0.03 | 0.074 | Glycine transporter 2 inhibitor | 0.074 0.019 CID_8663 0.042 0.037 CID_7005 | CID_8663 | |
| 0.06 | 0.039 | 0.06 | Cathepsin L inhibitor | |||
| 0.054 | 0.033 | 0.054 | Thromboxane A2 antagonist | 0.051 0.035 CID_11318 0.052 0.034 CID_7005 | ||
| 0.03 | 0.009 | 0.03 | Geranylgeranyltransferase inhibitor | |||
| 0.085 | 0.064 | 0.085 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.057 | 0.036 | 0.105 | Protein kinase C eta inhibitor | 0.105 0.016 CID_11318 0.086 0.021 CID_8663 0.048 0.046 CID_7005 | CID_11318 | |
| 0.032 | 0.012 | 0.043 | Dopamine autoreceptor agonist | 0.043 0.009 CID_8663 0.03 0.013 CID_7005 | CID_8663 | |
| 0.033 | 0.013 | 0.033 | LFA antagonist | |||
| 0.073 | 0.053 | 0.073 | Rho-associated kinase II inhibitor | |||
| 0.08 | 0.061 | 0.08 | Ca(v)3.1 blocker | |||
| 0.058 | 0.038 | 0.058 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.059 | 0.04 | 0.059 | Adenosine A1 receptor antagonist | 0.054 0.044 CID_7005 | ||
| 0.037 | 0.018 | 0.037 | Purinergic P2Y2 antagonist | 0.031 0.027 CID_11318 0.036 0.02 CID_7005 | ||
| 0.023 | 0.004 | 0.023 | Thromboxane A2 agonist | 0.014 0.013 CID_108063 0.015 0.012 CID_11318 0.017 0.009 CID_8663 0.017 0.009 CID_7005 | ||
| 0.033 | 0.014 | 0.033 | Lysine carboxypeptidase inhibitor | 0.028 0.018 CID_8663 0.024 0.023 CID_7005 | ||
| 0.091 | 0.073 | 0.091 | Check point kinase 2 inhibitor | |||
| 0.031 | 0.012 | 0.031 | Prostaglandin H2 antagonist | 0.023 0.02 CID_8663 0.029 0.014 CID_7005 | ||
| 0.023 | 0.005 | 0.023 | Telomerase stimulant | 0.016 0.014 CID_108063 0.02 0.008 CID_11318 0.021 0.006 CID_8663 0.021 0.006 CID_7005 | ||
| 0.055 | 0.037 | 0.056 | Thromboxane antagonist | 0.052 0.039 CID_11318 0.047 0.046 CID_8663 0.056 0.036 CID_7005 | CID_7005 | |
| 0.109 | 0.091 | 0.177 | Acetylcholinesterase inhibitor | 0.177 0.041 CID_11318 0.139 0.063 CID_8663 0.164 0.047 CID_7005 | CID_11318 | |
| 0.025 | 0.007 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.022 0.012 CID_8663 0.022 0.012 CID_7005 | ||
| 0.035 | 0.017 | 0.035 | Peptide deformylase inhibitor | |||
| 0.189 | 0.171 | 0.238 | Thyroid hormone antagonist | 0.201 0.161 CID_11318 0.197 0.164 CID_8663 0.238 0.132 CID_7005 | CID_7005 | |
| 0.049 | 0.032 | 0.049 | Glycine transporter inhibitor | |||
| 0.03 | 0.012 | 0.03 | Prostaglandin EP2 agonist | 0.024 0.015 CID_8663 0.023 0.016 CID_7005 | ||
| 0.04 | 0.023 | 0.04 | Factor XIIIa inhibitor | |||
| 0.061 | 0.044 | 0.061 | Acetylcholine M2 receptor antagonist | |||
| 0.041 | 0.023 | 0.041 | 5-Alpha-reductase inhibitor | 0.038 0.025 CID_8663 | ||
| 0.063 | 0.046 | 0.063 | Kallikrein 7 inhibitor | |||
| 0.043 | 0.026 | 0.043 | Cathepsin F inhibitor | |||
| 0.025 | 0.008 | 0.025 | Factor XIII inhibitor | |||
| 0.031 | 0.014 | 0.031 | NMDA 2D receptor antagonist | 0.03 0.015 CID_8663 | ||
| 0.064 | 0.047 | 0.064 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.03 | 0.013 | 0.03 | NMDA receptor glycine site antagonist | 0.027 0.015 CID_8663 0.024 0.018 CID_7005 | ||
| 0.03 | 0.014 | 0.035 | CXC chemokine 2 receptor antagonist | 0.028 0.017 CID_11318 0.031 0.013 CID_8663 0.035 0.01 CID_7005 | CID_7005 | |
| 0.037 | 0.021 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.046 0.015 CID_8663 0.037 0.021 CID_7005 | CID_8663 | |
| 0.026 | 0.009 | 0.026 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.02 | 0.004 | 0.02 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.032 | 0.016 | 0.044 | Liver X receptor alpha antagonist | 0.034 0.013 CID_11318 0.044 0.007 CID_8663 0.039 0.01 CID_7005 | CID_8663 | |
| 0.022 | 0.006 | 0.022 | CXC chemokine 5 receptor antagonist | |||
| 0.027 | 0.011 | 0.027 | Adenosine kinase inhibitor | |||
| 0.032 | 0.017 | 0.032 | Cyclin E2 inhibitor | |||
| 0.054 | 0.039 | 0.054 | Pim-2 kinase inhibitor | |||
| 0.022 | 0.006 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CID_11318 0.018 0.013 CID_8663 0.018 0.013 CID_7005 | ||
| 0.031 | 0.016 | 0.031 | CDK4/cyclin D3 inhibitor | |||
| 0.096 | 0.081 | 0.096 | Polo-like kinase-4 inhibitor | |||
| 0.057 | 0.042 | 0.057 | Calcium channel T-type blocker | |||
| 0.04 | 0.025 | 0.04 | G protein-coupled receptor agonist | |||
| 0.025 | 0.01 | 0.025 | Apolipoprotein B inhibitor | |||
| 0.023 | 0.009 | 0.023 | Toll-Like receptor 8 agonist | |||
| 0.059 | 0.044 | 0.106 | Bcl-xL inhibitor | 0.106 0.005 CID_11318 0.057 0.049 CID_8663 0.062 0.034 CID_7005 | CID_11318 | |
| 0.036 | 0.021 | 0.036 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.033 | 0.019 | 0.047 | Liver X receptor antagonist | 0.032 0.02 CID_11318 0.047 0.011 CID_8663 0.038 0.015 CID_7005 | CID_8663 | |
| 0.031 | 0.017 | 0.031 | Thrombin receptor antagonist | |||
| 0.035 | 0.021 | 0.035 | Carnitine palmitoyltransferase inhibitor | |||
| 0.044 | 0.03 | 0.047 | Liver X receptor agonist | 0.047 0.025 CID_8663 | CID_8663 | |
| 0.045 | 0.031 | 0.045 | 5 Hydroxytryptamine 2C agonist | |||
| 0.033 | 0.019 | 0.036 | Prostaglandin agonist | 0.031 0.021 CID_11318 0.031 0.021 CID_8663 0.036 0.016 CID_7005 | CID_7005 | |
| 0.018 | 0.004 | 0.018 | Progesterone receptor A antagonist | 0.013 0.004 CID_108063 0.009 0.007 CID_11318 0.013 0.004 CID_8663 0.011 0.005 CID_7005 | ||
| 0.162 | 0.149 | 0.433 | ErbB-1 antagonist | 0.433 0.013 CID_108063 0.237 0.059 CID_8663 | CID_108063 | |
| 0.024 | 0.01 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.034 | 0.021 | 0.038 | Melatonin 2 agonist | 0.038 0.017 CID_11318 0.038 0.018 CID_8663 0.034 0.022 CID_7005 | CID_8663 | |
| 0.02 | 0.007 | 0.02 | Nicotinic alpha4 receptor agonist | |||
| 0.048 | 0.035 | 0.048 | Metalloproteinase-3 inhibitor | |||
| 0.044 | 0.031 | 0.044 | Dipeptidyl peptidase IV inhibitor | |||
| 0.053 | 0.039 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.018 | 0.005 | 0.018 | Carbonic anhydrase XI inhibitor | |||
| 0.063 | 0.05 | 0.063 | Matrix metalloproteinase inhibitor | |||
| 0.021 | 0.008 | 0.031 | Estrogen-related receptor gamma agonist | 0.026 0.005 CID_11318 0.031 0.004 CID_8663 0.025 0.005 CID_7005 | CID_8663 | |
| 0.048 | 0.036 | 0.048 | Transforming growth factor beta 1 antagonist | |||
| 0.045 | 0.032 | 0.056 | Beta adrenoreceptor agonist | 0.051 0.016 CID_11318 0.056 0.011 CID_8663 0.05 0.018 CID_7005 | CID_8663 | |
| 0.041 | 0.028 | 0.041 | Neurokinin 2 agonist | |||
| 0.053 | 0.04 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.095 | 0.082 | 0.095 | Factor V inhibitor | |||
| 0.035 | 0.023 | 0.035 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.076 | 0.064 | 0.082 | Protein kinase A inhibitor | 0.082 0.058 CID_11318 | CID_11318 | |
| 0.021 | 0.009 | 0.021 | G-protein-coupled receptor 120 agonist | 0.018 0.011 CID_8663 0.016 0.013 CID_7005 | ||
| 0.017 | 0.005 | 0.017 | Glutamate (mGluR6) agonist | 0.014 0.006 CID_11318 0.014 0.007 CID_8663 0.014 0.007 CID_7005 | ||
| 0.09 | 0.078 | 0.09 | Insulin receptor antagonist | |||
| 0.04 | 0.029 | 0.04 | Toll-Like receptor 2 agonist | |||
| 0.016 | 0.005 | 0.017 | Egl nine homolog 3 inhibitor | 0.012 0.008 CID_11318 0.017 0.005 CID_8663 0.015 0.005 CID_7005 | CID_8663 | |
| 0.036 | 0.024 | 0.036 | AMPA receptor agonist | |||
| 0.016 | 0.005 | 0.016 | Cyclin D2 inhibitor | |||
| 0.182 | 0.171 | 0.222 | Thyroid hormone beta antagonist | 0.186 0.168 CID_11318 0.183 0.171 CID_8663 0.222 0.137 CID_7005 | CID_7005 | |
| 0.023 | 0.012 | 0.032 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.021 0.013 CID_11318 0.032 0.009 CID_8663 0.022 0.012 CID_7005 | CID_8663 | |
| 0.038 | 0.027 | 0.038 | Melanocortin 1 antagonist | |||
| 0.126 | 0.115 | 0.126 | Polo-like kinase-3 inhibitor | |||
| 0.014 | 0.003 | 0.014 | DNA topoisomerase III inhibitor | 0.007 0.005 CID_11318 0.008 0.004 CID_8663 0.008 0.004 CID_7005 | ||
| 0.018 | 0.007 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.074 | 0.063 | 0.074 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.016 | 0.005 | 0.016 | Melatonin 2 antagonist | |||
| 0.024 | 0.013 | 0.024 | Kainate receptor 1 antagonist | |||
| 0.066 | 0.056 | 0.066 | Alpha 1b adrenoreceptor antagonist | |||
| 0.033 | 0.023 | 0.033 | Prostacyclin antagonist | |||
| 0.033 | 0.023 | 0.033 | ATR kinase inhibitor | |||
| 0.038 | 0.028 | 0.038 | Cathepsin L1 inhibitor | |||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | 0.015 0.012 CID_11318 0.016 0.01 CID_8663 0.016 0.01 CID_7005 | ||
| 0.017 | 0.007 | 0.017 | Angiotensin AT1B receptor antagonist | |||
| 0.018 | 0.008 | 0.018 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.027 | 0.017 | 0.05 | Thyroid hormone agonist | 0.038 0.007 CID_11318 0.045 0.005 CID_8663 0.05 0.004 CID_7005 | CID_7005 | |
| 0.048 | 0.039 | 0.048 | Sodium/calcium exchanger inhibitor | |||
| 0.099 | 0.09 | 0.099 | TRKA antagonist | |||
| 0.014 | 0.005 | 0.014 | Angiotensin AT2 receptor agonist | |||
| 0.033 | 0.024 | 0.033 | Calcitonin receptor agonist | 0.031 0.026 CID_8663 | ||
| 0.12 | 0.111 | 0.165 | Insulin secretagoues | 0.163 0.062 CID_11318 0.143 0.082 CID_8663 0.165 0.06 CID_7005 | CID_7005 | |
| 0.019 | 0.01 | 0.028 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_11318 0.028 0.005 CID_8663 0.017 0.012 CID_7005 | CID_8663 | |
| 0.037 | 0.028 | 0.037 | DNA gyrase subunit B inhibitor | |||
| 0.219 | 0.211 | 0.287 | DNA polymerase beta inhibitor | 0.287 0.172 CID_11318 0.228 0.206 CID_8663 0.233 0.202 CID_7005 | CID_11318 | |
| 0.011 | 0.003 | 0.011 | CC chemokine 6 receptor agonist | |||
| 0.019 | 0.011 | 0.019 | Apolipoprotein B-100 inhibitor | |||
| 0.021 | 0.013 | 0.024 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.017 0.016 CID_8663 0.024 0.011 CID_7005 | CID_7005 | |
| 0.018 | 0.01 | 0.018 | CC chemokine 9 receptor antagonist | |||
| 0.076 | 0.068 | 0.076 | Phosphodiesterase XI inhibitor | |||
| 0.076 | 0.068 | 0.076 | Phosphodiesterase 11A inhibitor | |||
| 0.038 | 0.031 | 0.038 | DNA-dependent protein kinase inhibitor | |||
| 0.016 | 0.009 | 0.016 | CXC chemokine 4 receptor agonist | |||
| 0.046 | 0.038 | 0.046 | Adenosine A2b receptor antagonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | 0.018 0.017 CID_11318 0.018 0.017 CID_8663 0.02 0.013 CID_7005 | ||
| 0.051 | 0.043 | 0.051 | CC chemokine 2 receptor antagonist | |||
| 0.029 | 0.021 | 0.039 | Glucagon receptor antagonist | 0.026 0.024 CID_11318 0.029 0.021 CID_8663 0.039 0.014 CID_7005 | CID_7005 | |
| 0.093 | 0.086 | 0.23 | Protein-tyrosine phosphatase 1B inhibitor | 0.23 0.021 CID_11318 0.195 0.03 CID_8663 0.213 0.026 CID_7005 | CID_11318 | |
| 0.032 | 0.025 | 0.032 | Transforming growth factor beta 2 antagonist | |||
| 0.056 | 0.049 | 0.056 | Adenosine A2a receptor antagonist | |||
| 0.014 | 0.007 | 0.014 | Integrin beta2 antagonist | |||
| 0.062 | 0.055 | 0.062 | MAP kinase kinase 10 inhibitor | |||
| 0.033 | 0.026 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.018 CID_8663 | CID_8663 | |
| 0.03 | 0.023 | 0.042 | HCV NS5B polymerase inhibitor | 0.042 0.013 CID_8663 0.032 0.021 CID_7005 | CID_8663 | |
| 0.082 | 0.075 | 0.163 | ATPase (Vacuolar H+) inhibitor | 0.163 0.005 CID_108063 0.118 0.021 CID_11318 0.098 0.043 CID_8663 0.126 0.016 CID_7005 | CID_108063 | |
| 0.072 | 0.065 | 0.072 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.071 | 0.064 | 0.103 | Somatostatin 1 agonist | 0.103 0.032 CID_8663 0.071 0.064 CID_7005 | CID_8663 | |
| 0.045 | 0.038 | 0.456 | Estrogen agonist | 0.237 0.007 CID_11318 0.456 0.004 CID_8663 0.273 0.005 CID_7005 | CID_8663 | |
| 0.023 | 0.016 | 0.024 | Prostaglandin E2 agonist | 0.022 0.018 CID_11318 0.021 0.019 CID_8663 0.024 0.015 CID_7005 | CID_7005 | |
| 0.056 | 0.05 | 0.056 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.027 | 0.02 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.15 | 0.145 | 0.684 | Free radical scavenger | 0.206 0.093 CID_108063 0.684 0.005 CID_11318 0.534 0.013 CID_8663 0.52 0.014 CID_7005 | CID_11318 | |
| 0.031 | 0.026 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.014 | 0.009 | 0.014 | Melatonin receptor 1A antagonist | |||
| 0.031 | 0.026 | 0.031 | Carboxypeptidase B inhibitor | |||
| 0.015 | 0.01 | 0.02 | Egl nine homolog 1 inhibitor | 0.015 0.01 CID_11318 0.02 0.005 CID_8663 0.02 0.005 CID_7005 | CID_7005 | |
| 0.011 | 0.007 | 0.011 | Thromboxane agonist | |||
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | |||
| 0.026 | 0.022 | 0.026 | AMPA 1 receptor antagonist | |||
| 0.021 | 0.017 | 0.021 | Angiotensin AT1A receptor antagonist | |||
| 0.054 | 0.051 | 0.054 | Glutamate (mGluR) agonist | |||
| 0.047 | 0.043 | 0.054 | Ribonucleoside-diphosphate reductase inhibitor | 0.054 0.038 CID_8663 | CID_8663 | |
| 0.03 | 0.027 | 0.03 | Melatonin agonist | |||
| 0.074 | 0.07 | 0.074 | Neuropeptide Y antagonist | |||
| 0.01 | 0.007 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.024 | 0.021 | 0.024 | Sigma 2 receptor antagonist | 0.023 0.021 CID_8663 | ||
| 0.024 | 0.021 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.014 | 0.011 | 0.014 | Prostaglandin EP4 agonist | |||
| 0.054 | 0.051 | 0.054 | Dopamine D3 antagonist | 0.053 0.052 CID_11318 | ||
| 0.055 | 0.053 | 0.055 | Cannabinoid receptor agonist | |||
| 0.03 | 0.028 | 0.03 | Vanilloid 4 antagonist | |||
| 0.035 | 0.033 | 0.035 | Histone deacetylase class I inhibitor | |||
| 0.039 | 0.037 | 0.065 | DNA gyrase subunit A inhibitor | 0.046 0.023 CID_8663 0.065 0.008 CID_7005 | CID_7005 | |
| 0.059 | 0.057 | 0.059 | Phosphodiesterase 4B inhibitor | |||
| 0.047 | 0.045 | 0.054 | Ribonucleotide reductase inhibitor | 0.054 0.039 CID_8663 | CID_8663 | |
| 0.017 | 0.015 | 0.017 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.018 | 0.016 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.033 | 0.031 | 0.033 | Glutamate (mGluR8) antagonist | |||
| 0.023 | 0.021 | 0.023 | 5 Hydroxytryptamine 4 agonist | |||
| 0.017 | 0.015 | 0.017 | Histamine H4 receptor agonist | |||
| 0.05 | 0.049 | 0.05 | Alpha 1d adrenoreceptor antagonist | |||
| 0.011 | 0.009 | 0.011 | Thrombopoietin agonist | |||
| 0.013 | 0.012 | 0.013 | Adenosine A2a receptor agonist | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.047 | 0.048 | 0.136 | NMDA 2B receptor antagonist | 0.136 0.01 CID_8663 | CID_8663 | |
| 0.035 | 0.036 | 0.049 | Retinoic acid alpha receptor agonist | 0.049 0.015 CID_7005 | CID_7005 | |
| 0.058 | 0.059 | 0.125 | Leukotriene synthesis inhibitor | 0.116 0.018 CID_11318 0.125 0.015 CID_8663 0.108 0.022 CID_7005 | CID_8663 | |
| 0.038 | 0.04 | 0.046 | Urokinase inhibitor | 0.046 0.034 CID_11318 | CID_11318 | |
| 0.004 | 0.006 | 0.007 | Transcortin receptor antagonist | 0.007 0.004 CID_8663 | CID_8663 | |
| 0.027 | 0.029 | 0.298 | Estrogen receptor alpha agonist | 0.131 0.006 CID_11318 0.298 0.004 CID_8663 0.161 0.005 CID_7005 | CID_8663 | |
| 0.04 | 0.042 | 0.042 | Peroxisome proliferator-activated receptor alpha agonist | 0.042 0.039 CID_8663 | CID_8663 | |
| 0.019 | 0.023 | 0.029 | Beta 1 adrenoreceptor agonist | 0.024 0.013 CID_11318 0.029 0.009 CID_8663 0.023 0.015 CID_7005 | CID_8663 | |
| 0.045 | 0.05 | 0.067 | Factor III inhibitor | 0.067 0.013 CID_11318 0.061 0.016 CID_8663 0.046 0.045 CID_7005 | CID_11318 | |
| 0.058 | 0.063 | 0.069 | Sirtuin 1 inhibitor | 0.069 0.046 CID_8663 0.069 0.046 CID_7005 | CID_7005 | |
| 0.004 | 0.01 | 0.01 | Insulin like growth factor 3 antagonist | 0.01 0.003 CID_11318 0.008 0.003 CID_8663 | CID_11318 | |
| 0.212 | 0.219 | 0.286 | DNA directed DNA polymerase inhibitor | 0.286 0.169 CID_11318 0.224 0.209 CID_8663 0.236 0.2 CID_7005 | CID_11318 | |
| 0.057 | 0.065 | 0.062 | Prolactin release inhibitor | 0.062 0.043 CID_8663 0.059 0.056 CID_7005 | CID_8663 | |
| 0.005 | 0.014 | 0.014 | Thyroid hormone beta agonist | 0.009 0.005 CID_11318 0.011 0.005 CID_8663 0.014 0.004 CID_7005 | CID_7005 | |
| 0.016 | 0.025 | 0.019 | Retinoic acid beta receptor agonist | 0.019 0.016 CID_7005 | CID_7005 | |
| 0.099 | 0.107 | 0.108 | Sphingosine 1-phosphate receptor 2 agonist | 0.108 0.079 CID_8663 | CID_8663 | |
| 0.02 | 0.029 | 0.364 | Estrogen receptor beta agonist | 0.047 0.02 CID_108063 0.147 0.007 CID_11318 0.364 0.003 CID_8663 0.201 0.005 CID_7005 | CID_8663 | |
| 0.043 | 0.055 | 0.078 | Plasminogen activator inhibitor | 0.078 0.027 CID_11318 0.053 0.045 CID_7005 | CID_11318 | |
| 0.027 | 0.04 | 0.033 | Protein kinase C beta II inhibitor | 0.033 0.021 CID_11318 0.032 0.023 CID_8663 | CID_11318 | |
| 0.009 | 0.024 | 0.015 | Calcium-sensing receptor antagonist | 0.015 0.01 CID_7005 | CID_7005 | |
| 0.041 | 0.056 | 0.273 | Alpha tubulin antagonist | 0.225 0.005 CID_11318 0.169 0.008 CID_8663 0.273 0.004 CID_7005 | CID_7005 | |
| 0.015 | 0.031 | 0.051 | Leukotriene B4 receptor 2 antagonist | 0.029 0.009 CID_11318 0.022 0.016 CID_8663 0.051 0.004 CID_7005 | CID_7005 | |
| 0.053 | 0.069 | 0.084 | Bcl2 antagonist | 0.084 0.029 CID_11318 | CID_11318 | |
| 0.025 | 0.042 | 0.178 | Catechol O-methyltransferase inhibitor | 0.178 0.003 CID_11318 0.099 0.005 CID_8663 0.059 0.007 CID_7005 | CID_11318 | |
| 0.048 | 0.066 | 0.076 | Adenine nucleotide translocase inhibitor | 0.075 0.012 CID_11318 0.076 0.011 CID_8663 0.071 0.014 CID_7005 | CID_8663 | |
| 0.007 | 0.025 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.01 CID_7005 | CID_7005 | |
| 0.084 | 0.102 | 0.096 | mTOR complex 1 inhibitor | 0.096 0.071 CID_108063 | CID_108063 | |
| 0.108 | 0.126 | 0.12 | Cholinergic | 0.12 0.108 CID_11318 0.116 0.113 CID_7005 | CID_11318 | |
| 0.11 | 0.129 | 0.217 | Farnesoid X receptor antagonist | 0.151 0.051 CID_11318 0.217 0.017 CID_8663 0.162 0.041 CID_7005 | CID_8663 | |
| 0.013 | 0.032 | 0.023 | Retinoic acid alpha receptor antagonist | 0.018 0.017 CID_11318 0.023 0.011 CID_7005 | CID_7005 | |
| 0.012 | 0.031 | 0.018 | Retinoic acid receptor antagonist | 0.018 0.013 CID_7005 | CID_7005 | |
| 0.073 | 0.093 | 0.102 | Interleukin 5 antagonist | 0.102 0.039 CID_8663 0.084 0.064 CID_7005 | CID_8663 | |
| 0.052 | 0.072 | 0.068 | Dopamine antagonist | 0.068 0.055 CID_11318 | CID_11318 | |
| 0.015 | 0.037 | 0.021 | CYP24 inhibitor | 0.021 0.019 CID_8663 | CID_8663 | |
| 0.147 | 0.169 | 0.663 | Antioxidant | 0.313 0.057 CID_108063 0.663 0.007 CID_11318 0.522 0.018 CID_8663 0.513 0.019 CID_7005 | CID_11318 | |
| 0.028 | 0.05 | 0.04 | Erythropoietin receptor agonist | 0.038 0.031 CID_8663 0.04 0.028 CID_7005 | CID_7005 | |
| 0.112 | 0.136 | 0.471 | Mcl-1 antagonist | 0.471 0.007 CID_11318 0.227 0.044 CID_8663 0.351 0.015 CID_7005 | CID_11318 | |
| 0.073 | 0.098 | 0.282 | Topoisomerase I inhibitor | 0.282 0.013 CID_11318 0.255 0.016 CID_8663 0.262 0.015 CID_7005 | CID_11318 | |
| 0.085 | 0.11 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 CID_8663 0.105 0.07 CID_7005 | CID_8663 | |
| 0.025 | 0.05 | 0.045 | Dopamine D3 agonist | 0.045 0.023 CID_11318 0.038 0.029 CID_7005 | CID_11318 | |
| 0.046 | 0.072 | 0.507 | HIV-1 integrase (3'-Processing) inhibitor | 0.097 0.027 CID_108063 0.507 0.003 CID_11318 0.182 0.011 CID_8663 0.236 0.007 CID_7005 | CID_11318 | |
| 0.023 | 0.049 | 0.037 | Cathepsin L2 inhibitor | 0.037 0.031 CID_11318 | CID_11318 | |
| 0.091 | 0.118 | 0.184 | M17 leucyl aminopeptidase inhibitor | 0.184 0.038 CID_108063 0.106 0.093 CID_8663 | CID_108063 | |
| 0.036 | 0.064 | 0.253 | Beta tubulin antagonist | 0.253 0.005 CID_11318 0.159 0.011 CID_8663 0.253 0.005 CID_7005 | CID_7005 | |
| 0.015 | 0.043 | 0.05 | Leukotriene B4 receptor 1 antagonist | 0.029 0.019 CID_11318 0.026 0.021 CID_8663 0.05 0.007 CID_7005 | CID_7005 | |
| 0.087 | 0.116 | 0.125 | Electron transport complex I inhibitor | 0.106 0.069 CID_11318 0.101 0.081 CID_8663 0.125 0.041 CID_7005 | CID_7005 | |
| 0.041 | 0.069 | 0.055 | Dopamine D2 antagonist | 0.055 0.053 CID_11318 | CID_11318 | |
| 0.046 | 0.08 | 0.062 | Transcription factor AP-1 inhibitor | 0.062 0.042 CID_11318 | CID_11318 | |
| 0.016 | 0.05 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 CID_7005 | CID_7005 | |
| 0.092 | 0.126 | 0.202 | Interleukin 2 antagonist | 0.202 0.008 CID_108063 | CID_108063 | |
| 0.023 | 0.058 | 0.242 | Dopamine D5 antagonist | 0.242 0.004 CID_108063 0.212 0.005 CID_11318 0.067 0.016 CID_8663 | CID_108063 | |
| 0.01 | 0.046 | 0.027 | Estrone sulfatase inhibitor | 0.027 0.012 CID_8663 | CID_8663 | |
| 0.114 | 0.15 | 0.443 | Dual specificity phosphatase inhibitor | 0.443 0.01 CID_11318 0.204 0.053 CID_8663 0.36 0.019 CID_7005 | CID_11318 | |
| 0.127 | 0.164 | 0.17 | Hypolipemic | 0.17 0.118 CID_8663 0.165 0.122 CID_7005 | CID_8663 | |
| 0.027 | 0.066 | 0.064 | Phosphodiesterase 3B inhibitor | 0.064 0.018 CID_8663 | CID_8663 | |
| 0.04 | 0.08 | 0.479 | Dopamine agonist | 0.479 0.004 CID_11318 0.106 0.025 CID_8663 0.095 0.029 CID_7005 | CID_11318 | |
| 0.02 | 0.064 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 CID_8663 | CID_8663 | |
| 0.121 | 0.165 | 0.204 | P-glycoprotein inhibitor | 0.204 0.061 CID_11318 0.179 0.08 CID_8663 0.165 0.096 CID_7005 | CID_11318 | |
| 0.029 | 0.074 | 0.18 | Aldose reductase inhibitor | 0.18 0.008 CID_11318 0.114 0.015 CID_8663 0.116 0.015 CID_7005 | CID_11318 | |
| 0.079 | 0.125 | 0.209 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.209 0.039 CID_11318 0.193 0.044 CID_8663 0.11 0.091 CID_7005 | CID_11318 | |
| 0.036 | 0.082 | 0.065 | Myc inhibitor | 0.065 0.023 CID_108063 | CID_108063 | |
| 0.037 | 0.084 | 0.078 | Glucose-6-phosphate translocase inhibitor | 0.078 0.012 CID_11318 0.062 0.022 CID_8663 0.049 0.04 CID_7005 | CID_11318 | |
| 0.022 | 0.069 | 0.394 | Dopamine D2 agonist | 0.394 0.004 CID_11318 0.075 0.015 CID_8663 0.074 0.016 CID_7005 | CID_11318 | |
| 0.082 | 0.131 | 0.2 | Bone formation stimulant | 0.2 0.036 CID_11318 0.195 0.037 CID_8663 0.16 0.052 CID_7005 | CID_11318 | |
| 0.012 | 0.062 | 0.185 | Dopamine D1 agonist | 0.185 0.003 CID_11318 0.038 0.006 CID_8663 0.03 0.009 CID_7005 | CID_11318 | |
| 0.011 | 0.061 | 0.022 | Antibiotic Tetracycline-like | 0.015 0.011 CID_11318 0.015 0.013 CID_8663 0.022 0.004 CID_7005 | CID_7005 | |
| 0.076 | 0.127 | 0.147 | Toll-Like receptor 4 antagonist | 0.135 0.031 CID_11318 0.147 0.023 CID_8663 0.112 0.052 CID_7005 | CID_8663 | |
| 0.034 | 0.085 | 0.423 | HIV-1 integrase (Strand Transfer) inhibitor | 0.423 0.004 CID_11318 0.139 0.014 CID_8663 0.21 0.009 CID_7005 | CID_11318 | |
| 0.045 | 0.098 | 0.069 | Phosphodiesterase 4D inhibitor | 0.069 0.056 CID_8663 | CID_8663 | |
| 0.031 | 0.084 | 0.04 | VCAM-1 antagonist | 0.04 0.026 CID_7005 | CID_7005 | |
| 0.03 | 0.085 | 0.04 | VCAM antagonist | 0.04 0.026 CID_7005 | CID_7005 | |
| 0.017 | 0.072 | 0.059 | Estrogen-related receptor alpha antagonist | 0.059 0.011 CID_8663 0.032 0.024 CID_7005 | CID_8663 | |
| 0.102 | 0.158 | 0.399 | Dual specificity phosphatase 3 inhibitor | 0.399 0.014 CID_11318 0.213 0.054 CID_8663 0.257 0.038 CID_7005 | CID_11318 | |
| 0.014 | 0.071 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.029 0.017 CID_8663 0.031 0.014 CID_7005 | CID_7005 | |
| 0.047 | 0.104 | 0.067 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.067 0.064 CID_8663 | CID_8663 | |
| 0.045 | 0.103 | 0.055 | Gonadotropin-releasing hormone receptor agonist | 0.055 0.051 CID_8663 | CID_8663 | |
| 0.042 | 0.101 | 0.064 | Check point kinase 1 inhibitor | 0.064 0.052 CID_8663 | CID_8663 | |
| 0.016 | 0.076 | 0.036 | CC chemokine 8 receptor antagonist | 0.036 0.004 CID_108063 | CID_108063 | |
| 0.051 | 0.112 | 0.071 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.071 0.067 CID_8663 | CID_8663 | |
| 0.027 | 0.089 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.033 CID_7005 | CID_7005 | |
| 0.045 | 0.111 | 0.1 | Histone deacetylase SIRT1 stimulant | 0.1 0.028 CID_8663 | CID_8663 | |
| 0.045 | 0.111 | 0.1 | Histone deacetylase stimulant | 0.1 0.028 CID_8663 | CID_8663 | |
| 0.008 | 0.074 | 0.024 | Thyroid hormone alpha agonist | 0.018 0.009 CID_11318 0.016 0.013 CID_8663 0.024 0.005 CID_7005 | CID_7005 | |
| 0.048 | 0.115 | 0.295 | HIV-1 integrase inhibitor | 0.295 0.004 CID_11318 0.13 0.012 CID_8663 0.145 0.009 CID_7005 | CID_11318 | |
| 0.03 | 0.101 | 0.072 | Purinergic P2X2 antagonist | 0.072 0.045 CID_8663 | CID_8663 | |
| 0.033 | 0.106 | 0.071 | Phosphodiesterase III inhibitor | 0.071 0.043 CID_8663 | CID_8663 | |
| 0.063 | 0.141 | 0.147 | c-Src kinase inhibitor | 0.147 0.056 CID_108063 | CID_108063 | |
| 0.051 | 0.133 | 0.178 | Opioid kappa receptor antagonist | 0.093 0.042 CID_11318 0.178 0.013 CID_8663 0.084 0.053 CID_7005 | CID_8663 | |
| 0.054 | 0.137 | 0.162 | Bronchodilator | 0.096 0.069 CID_11318 0.162 0.028 CID_8663 0.104 0.059 CID_7005 | CID_8663 | |
| 0.038 | 0.122 | 0.088 | Cyclin B3 inhibitor | 0.088 0.034 CID_7005 | CID_7005 | |
| 0.098 | 0.184 | 0.353 | Nitric oxide antagonist | 0.281 0.044 CID_108063 0.353 0.031 CID_11318 0.269 0.047 CID_8663 0.261 0.049 CID_7005 | CID_11318 | |
| 0.032 | 0.122 | 0.081 | HIV-1 reverse transcriptase inhibitor | 0.081 0.041 CID_11318 | CID_11318 | |
| 0.075 | 0.166 | 0.158 | Thrombolytic | 0.154 0.079 CID_11318 0.158 0.075 CID_8663 0.14 0.09 CID_7005 | CID_8663 | |
| 0.025 | 0.117 | 0.117 | Maillard reaction inhibitor | 0.084 0.023 CID_11318 0.079 0.025 CID_8663 0.117 0.011 CID_7005 | CID_7005 | |
| 0.006 | 0.098 | 0.032 | Thyroid hormone alpha antagonist | 0.016 0.01 CID_11318 0.017 0.009 CID_8663 0.032 0.005 CID_7005 | CID_7005 | |
| 0.066 | 0.159 | 0.108 | Nav1.4 sodium channel blocker | 0.108 0.064 CID_8663 | CID_8663 | |
| 0.03 | 0.126 | 0.071 | CXC chemokine 1 receptor antagonist | 0.06 0.021 CID_11318 0.068 0.014 CID_8663 0.071 0.012 CID_7005 | CID_7005 | |
| 0.138 | 0.235 | 0.493 | Thioredoxin glutathione reductase inhibitor | 0.493 0.03 CID_108063 0.257 0.129 CID_11318 0.19 0.181 CID_7005 | CID_108063 | |
| 0.013 | 0.112 | 0.049 | Opioid delta receptor agonist | 0.049 0.014 CID_8663 | CID_8663 | |
| 0.05 | 0.15 | 0.174 | Antineoplastic alkaloid | 0.174 0.021 CID_108063 0.078 0.068 CID_11318 0.144 0.029 CID_8663 | CID_108063 | |
| 0.162 | 0.266 | 0.289 | Interleukin 2 agonist | 0.289 0.082 CID_8663 0.224 0.151 CID_7005 | CID_8663 | |
| 0.01 | 0.115 | 0.057 | Glucocorticoid antagonist | 0.057 0.012 CID_108063 | CID_108063 | |
| 0.056 | 0.163 | 0.44 | Chelator | 0.44 0.005 CID_11318 0.252 0.016 CID_8663 0.328 0.009 CID_7005 | CID_11318 | |
| 0.037 | 0.148 | 0.292 | MAP3K7 inhibitor | 0.292 0.004 CID_108063 | CID_108063 | |
| 0.148 | 0.258 | 0.639 | Immunosuppressant | 0.639 0.009 CID_108063 0.351 0.086 CID_11318 0.262 0.139 CID_8663 0.333 0.095 CID_7005 | CID_108063 | |
| 0.051 | 0.165 | 0.113 | Aminoacyl-tRNA synthetase inhibitor | 0.113 0.034 CID_7005 | CID_7005 | |
| 0.021 | 0.136 | 0.162 | Opioid delta receptor antagonist | 0.07 0.04 CID_11318 0.162 0.017 CID_8663 0.057 0.048 CID_7005 | CID_8663 | |
| 0.023 | 0.146 | 0.153 | Opioid mu receptor antagonist | 0.063 0.051 CID_11318 0.153 0.017 CID_8663 | CID_8663 | |
| 0.043 | 0.167 | 0.174 | Opioid antagonist | 0.083 0.065 CID_11318 0.174 0.019 CID_8663 0.08 0.069 CID_7005 | CID_8663 | |
| 0.04 | 0.165 | 0.089 | Antiadrenergic | 0.089 0.063 CID_11318 | CID_11318 | |
| 0.038 | 0.165 | 0.086 | Adrenaline antagonist | 0.086 0.063 CID_11318 | CID_11318 | |
| 0.036 | 0.172 | 0.179 | Acetylcholine M3 receptor agonist | 0.179 0.008 CID_108063 | CID_108063 | |
| 0.061 | 0.197 | 0.127 | Interleukin 12 antagonist | 0.127 0.024 CID_8663 0.105 0.046 CID_7005 | CID_8663 | |
| 0.057 | 0.194 | 0.114 | Vanilloid agonist | 0.114 0.022 CID_11318 0.101 0.032 CID_8663 0.09 0.046 CID_7005 | CID_11318 | |
| 0.035 | 0.172 | 0.123 | Analgesic, opioid | 0.123 0.021 CID_8663 | CID_8663 | |
| 0.06 | 0.199 | 0.394 | Lipid peroxidase inhibitor | 0.394 0.01 CID_11318 0.326 0.015 CID_8663 0.308 0.018 CID_7005 | CID_11318 | |
| 0.022 | 0.165 | 0.124 | Selectin antagonist | 0.124 0.021 CID_11318 | CID_11318 | |
| 0.052 | 0.202 | 0.191 | DNA polymerase I inhibitor | 0.186 0.033 CID_11318 0.174 0.038 CID_8663 0.191 0.031 CID_7005 | CID_7005 | |
| 0.096 | 0.255 | 0.315 | Vasodilator | 0.315 0.043 CID_11318 0.215 0.093 CID_8663 0.179 0.122 CID_7005 | CID_11318 | |
| 0.011 | 0.177 | 0.088 | Opioid mu receptor agonist | 0.088 0.016 CID_8663 | CID_8663 | |
| 0.018 | 0.184 | 0.033 | Tubulin agonist | 0.033 0.027 CID_108063 0.032 0.031 CID_11318 | CID_108063 | |
| 0.075 | 0.248 | 0.736 | Antimitotic | 0.736 0.004 CID_108063 0.28 0.049 CID_11318 0.186 0.092 CID_8663 | CID_108063 | |
| 0.013 | 0.187 | 0.071 | Opioid agonist | 0.071 0.022 CID_8663 | CID_8663 | |
| 0.076 | 0.256 | 0.299 | Hepatoprotectant | 0.148 0.112 CID_108063 0.299 0.03 CID_11318 0.21 0.059 CID_8663 0.216 0.056 CID_7005 | CID_11318 | |
| 0.099 | 0.283 | 0.315 | Hypoglycemic | 0.297 0.054 CID_11318 0.296 0.054 CID_8663 0.315 0.048 CID_7005 | CID_7005 | |
| 0.012 | 0.198 | 0.049 | Opioid kappa receptor agonist | 0.049 0.025 CID_8663 | CID_8663 | |
| 0.073 | 0.266 | 0.212 | Platelet adhesion inhibitor | 0.197 0.073 CID_108063 0.212 0.065 CID_11318 0.154 0.101 CID_8663 0.165 0.091 CID_7005 | CID_11318 | |
| 0.173 | 0.376 | 0.561 | Antiinflammatory | 0.561 0.065 CID_11318 0.412 0.132 CID_8663 0.451 0.11 CID_7005 | CID_11318 | |
| 0.027 | 0.232 | 0.071 | Vanilloid 2 antagonist | 0.071 0.013 CID_11318 0.053 0.035 CID_8663 0.057 0.027 CID_7005 | CID_11318 | |
| 0.035 | 0.255 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 CID_8663 | CID_8663 | |
| 0.012 | 0.244 | 0.391 | Antineoplastic antibiotic | 0.391 0.005 CID_108063 0.141 0.033 CID_11318 0.071 0.064 CID_8663 0.143 0.032 CID_7005 | CID_108063 | |
| 0.013 | 0.248 | 0.061 | Acetylcholine M2 receptor agonist | 0.061 0.027 CID_108063 | CID_108063 | |
| 0.008 | 0.253 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 CID_7005 | CID_7005 | |
| 0.014 | 0.263 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_11318 | CID_11318 | |
| 0.047 | 0.306 | 0.287 | Angiogenesis stimulant | 0.287 0.054 CID_11318 0.244 0.073 CID_8663 0.27 0.061 CID_7005 | CID_11318 | |
| 0.133 | 0.395 | 0.348 | Cyclophilin D inhibitor | 0.348 0.123 CID_11318 0.271 0.19 CID_8663 0.308 0.156 CID_7005 | CID_11318 | |
| 0.106 | 0.385 | 0.229 | Peptidyltransferase inhibitor | 0.205 0.092 CID_11318 0.21 0.087 CID_8663 0.229 0.068 CID_7005 | CID_7005 | |
| 0.009 | 0.382 | 0.068 | Microtubule stabilization | 0.068 0.008 CID_108063 | CID_108063 | |
| 0.012 | 0.4 | 0.109 | Neuraminidase (influenza) inhibitor | 0.109 0.014 CID_11318 | CID_11318 | |
| 0.008 | 0.403 | 0.099 | Neuraminidase inhibitor | 0.099 0.015 CID_11318 | CID_11318 | |
| 0.001 | 0.423 | 0.024 | Antibiotic Macrolide-like | 0.024 0.005 CID_108063 | CID_108063 | |
| 0.059 | 0.529 | 0.282 | Immunomodulator | 0.282 0.093 CID_108063 | CID_108063 | |
| 0.01 | 0.48 | 0.1 | Protein 50S ribosomal subunit inhibitor | 0.1 0.013 CID_108063 | CID_108063 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |